###begin article-title 0
###xml 94 95 94 95 <sub>2</sub>
###xml 99 104 <span type="species:ncbi:4932">yeast</span>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P2 in yeast and mouse
###end article-title 0
###begin p 1
These authors contributed equally to this work
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This licence does not permit commercial exploitation without specific permission.
###end p 2
###begin p 3
###xml 29 30 29 30 <sub>2</sub>
###xml 185 186 185 186 <sub>2</sub>
###xml 224 225 224 225 <sub>2</sub>
###xml 329 330 329 330 <sub>2</sub>
###xml 523 524 523 524 <sub>2</sub>
###xml 599 600 599 600 <sub>2</sub>
###xml 667 672 667 672 <italic>ingls</italic>
###xml 674 676 674 676 <underline>in</underline>
###xml 684 686 684 686 <underline>gl</underline>
###xml 688 689 688 689 <underline>s</underline>
###xml 827 832 827 832 <italic>ingls</italic>
###xml 914 915 914 915 <sub>2</sub>
###xml 1045 1046 1045 1046 <sub>2</sub>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 385 390 <span type="species:ncbi:4932">yeast</span>
###xml 654 659 <span type="species:ncbi:10090">mouse</span>
###xml 1157 1162 <span type="species:ncbi:10090">mouse</span>
The signalling lipid PI(3,5)P2 is generated on endosomes and regulates retrograde traffic to the trans-Golgi network. Physiological signals regulate rapid, transient changes in PI(3,5)P2 levels. Mutations that lower PI(3,5)P2 cause neurodegeneration in human patients and mice. The function of Vac14 in the regulation of PI(3,5)P2 was uncharacterized previously. Here, we predict that yeast and mammalian Vac14 are composed entirely of HEAT repeats and demonstrate that Vac14 exerts an effect as a scaffold for the PI(3,5)P2 regulatory complex by direct contact with the known regulators of PI(3,5)P2: Fig4, Fab1, Vac7 and Atg18. We also report that the mouse mutant ingls (infantile gliosis) results from a missense mutation in Vac14 that prevents the association of Vac14 with Fab1, generating a partial complex. Analysis of ingls and two additional mutants provides insight into the organization of the PI(3,5)P2 regulatory complex and indicates that Vac14 mediates three distinct mechanisms for the rapid interconversion of PI3P and PI(3,5)P2. Moreover, these studies show that the association of Fab1 with the complex is essential for viability in the mouse.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 275 297 275 297 <xref ref-type="bibr" rid="b24">Matteis and Godi, 2004</xref>
###xml 299 321 299 321 <xref ref-type="bibr" rid="b2">Behnia and Munro, 2005</xref>
###xml 329 334 329 334 <italic>et al</italic>
###xml 323 340 323 340 <xref ref-type="bibr" rid="b3">Bolis <italic>et al</italic>, 2007</xref>
###xml 517 518 517 518 <sub>2</sub>
###xml 584 585 584 585 <sub>2</sub>
###xml 746 775 746 775 <xref ref-type="bibr" rid="b11">Di Paolo and De Camilli, 2006</xref>
###xml 786 787 786 787 <sub>2</sub>
###xml 969 974 969 974 <italic>et al</italic>
###xml 957 980 957 980 <xref ref-type="bibr" rid="b5">Bonangelino <italic>et al</italic>, 2002</xref>
###xml 987 992 987 992 <italic>et al</italic>
###xml 982 999 982 999 <xref ref-type="bibr" rid="b15">Duex <italic>et al</italic>, 2006b</xref>
###xml 1007 1012 1007 1012 <italic>et al</italic>
###xml 1001 1018 1001 1018 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 852 857 <span type="species:ncbi:4932">yeast</span>
Phosphoinositide phosphate (PIP) lipids are transiently generated on the cytoplasmic face of selected intracellular membranes. Spatial localization of the lipid kinases and phosphatases that generate specific PIPs produces unique PIP tags on different membrane compartments (Matteis and Godi, 2004; Behnia and Munro, 2005; Bolis et al, 2007). PIPs function through recruitment of specific effector proteins, which in turn regulate ion channels, membrane fission and fusion, and formation of membrane tubules. PI(3,5)P2 is synthesized by phosphorylation of PI3P. Both PI3P and PI(3,5)P2 are generated in the endomembrane system, a heterogeneous system of membranes involved in traffic to and from the plasma membrane, the lysosome, and the Golgi (Di Paolo and De Camilli, 2006). PI(3,5)P2 is a minor PIP present at <0.1 and <0.05% of total PI lipids in yeast and mammalian cells, respectively, compared with the more typical values of 2.5 and 0.2% for PI3P (Bonangelino et al, 2002; Duex et al, 2006b; Zhang et al, 2007).
###end p 5
###begin p 6
###xml 48 49 48 49 <sub>2</sub>
###xml 288 293 288 293 <italic>et al</italic>
###xml 276 299 276 299 <xref ref-type="bibr" rid="b4">Bonangelino <italic>et al</italic>, 1997</xref>
###xml 301 305 301 305 <xref ref-type="bibr" rid="b5">2002</xref>
###xml 312 317 312 317 <italic>et al</italic>
###xml 307 323 307 323 <xref ref-type="bibr" rid="b19">Gary <italic>et al</italic>, 1998</xref>
###xml 325 329 325 329 <xref ref-type="bibr" rid="b18">2002</xref>
###xml 336 341 336 341 <italic>et al</italic>
###xml 331 347 331 347 <xref ref-type="bibr" rid="b12">Dove <italic>et al</italic>, 2002</xref>
###xml 349 353 349 353 <xref ref-type="bibr" rid="b13">2004</xref>
###xml 361 366 361 366 <italic>et al</italic>
###xml 355 372 355 372 <xref ref-type="bibr" rid="b26">Rudge <italic>et al</italic>, 2004</xref>
###xml 379 384 379 384 <italic>et al</italic>
###xml 374 391 374 391 <xref ref-type="bibr" rid="b14">Duex <italic>et al</italic>, 2006a</xref>
###xml 393 398 393 398 <xref ref-type="bibr" rid="b15">2006b</xref>
###xml 404 409 404 409 <italic>et al</italic>
###xml 400 415 400 415 <xref ref-type="bibr" rid="b16">Efe <italic>et al</italic>, 2007</xref>
###xml 570 575 570 575 <italic>et al</italic>
###xml 558 581 558 581 <xref ref-type="bibr" rid="b5">Bonangelino <italic>et al</italic>, 2002</xref>
###xml 588 593 588 593 <italic>et al</italic>
###xml 583 599 583 599 <xref ref-type="bibr" rid="b13">Dove <italic>et al</italic>, 2004</xref>
###xml 607 612 607 612 <italic>et al</italic>
###xml 601 618 601 618 <xref ref-type="bibr" rid="b26">Rudge <italic>et al</italic>, 2004</xref>
###xml 625 630 625 630 <italic>et al</italic>
###xml 620 637 620 637 <xref ref-type="bibr" rid="b14">Duex <italic>et al</italic>, 2006a</xref>
###xml 667 672 667 672 <italic>et al</italic>
###xml 659 678 659 678 <xref ref-type="bibr" rid="b6">Botelho <italic>et al</italic>, 2008</xref>
###xml 834 839 834 839 <italic>et al</italic>
###xml 825 845 825 845 <xref ref-type="bibr" rid="b21">Ikonomov <italic>et al</italic>, 2006</xref>
###xml 858 863 858 863 <italic>et al</italic>
###xml 847 869 847 869 <xref ref-type="bibr" rid="b27">Rutherford <italic>et al</italic>, 2006</xref>
###xml 1010 1015 1010 1015 <italic>et al</italic>
###xml 1002 1021 1002 1021 <xref ref-type="bibr" rid="b28">Sbrissa <italic>et al</italic>, 2007</xref>
###xml 1122 1127 1122 1127 <italic>et al</italic>
###xml 1110 1133 1110 1133 <xref ref-type="bibr" rid="b4">Bonangelino <italic>et al</italic>, 1997</xref>
###xml 1140 1145 1140 1145 <italic>et al</italic>
###xml 1135 1152 1135 1152 <xref ref-type="bibr" rid="b15">Duex <italic>et al</italic>, 2006b</xref>
###xml 92 97 <span type="species:ncbi:4932">yeast</span>
###xml 488 493 <span type="species:ncbi:4932">yeast</span>
###xml 1044 1049 <span type="species:ncbi:4932">yeast</span>
The dynamic interconversion of PI3P and PI(3,5)P2 is regulated by at least five proteins in yeast: the lipid kinase Fab1p, lipid phosphatase Fig4p, the Fab1p activator Vac7p, the Fab1p inhibitor Atg18p, and Vac14p, a protein required for the activity of both Fab1p and Fig4p (Bonangelino et al, 1997, 2002; Gary et al, 1998, 2002; Dove et al, 2002, 2004; Rudge et al, 2004; Duex et al, 2006a, 2006b; Efe et al, 2007). Homologues of Fab1p, Vac14p and Fig4p are found in all eukaryotes. In yeast, Vac14p, Fab1p and Fig4p are localized on the vacuole membrane (Bonangelino et al, 2002; Dove et al, 2004; Rudge et al, 2004; Duex et al, 2006a) and form a complex (Botelho et al, 2008). In mammalian cells, these proteins, also known as Fab1/PIKfyve/PIP5K3, Fig4/Sac3, and Vac14/ArPIKfyve, are located on early and late endosomes (Ikonomov et al, 2006; Rutherford et al, 2006). Association of the three mammalian proteins in cultured cells has been demonstrated by coimmunoprecipitation and cosedimentation (Sbrissa et al, 2007). Genetic analysis in yeast shows that Vac14p is required for Fab1p and Fig4p function (Bonangelino et al, 1997; Duex et al, 2006b), but the mechanism of this regulation is not known.
###end p 6
###begin p 7
###xml 57 62 57 62 <italic>Vac14</italic>
###xml 67 71 67 71 <italic>Fig4</italic>
###xml 119 120 119 120 <sub>2</sub>
###xml 163 167 163 167 <italic>Fig4</italic>
###xml 175 186 175 186 <italic>pale tremor</italic>
###xml 463 468 463 468 <italic>et al</italic>
###xml 458 474 458 474 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 496 501 496 501 <italic>Vac14</italic>
###xml 583 588 583 588 <italic>et al</italic>
###xml 577 594 577 594 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 618 619 618 619 <sub>2</sub>
###xml 761 762 761 762 <sub>2</sub>
###xml 887 924 887 924 <xref ref-type="bibr" rid="b29">Volpicelli-Daley and De Camilli, 2007</xref>
###xml 1023 1027 1023 1027 <italic>Fig4</italic>
###xml 1029 1034 1029 1034 <italic>Vac14</italic>
###xml 1038 1042 1038 1042 <italic>Fab1</italic>
###xml 1053 1058 1053 1058 <italic>et al</italic>
###xml 1044 1064 1044 1064 <xref ref-type="bibr" rid="b21">Ikonomov <italic>et al</italic>, 2006</xref>
###xml 1077 1082 1077 1082 <italic>et al</italic>
###xml 1066 1088 1066 1088 <xref ref-type="bibr" rid="b27">Rutherford <italic>et al</italic>, 2006</xref>
###xml 1095 1100 1095 1100 <italic>et al</italic>
###xml 1090 1106 1090 1106 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 1114 1119 1114 1119 <italic>et al</italic>
###xml 1108 1125 1108 1125 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 1313 1317 1313 1317 <italic>Fig4</italic>
###xml 1402 1407 1402 1407 <italic>et al</italic>
###xml 1397 1413 1397 1413 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 1421 1426 1421 1426 <italic>et al</italic>
###xml 1415 1432 1415 1432 <xref ref-type="bibr" rid="b32">Zhang <italic>et al</italic>, 2008</xref>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 1232 1237 <span type="species:ncbi:9606">Human</span>
###xml 1238 1246 <span type="species:ncbi:9606">patients</span>
We recently described lethal null mutations of mammalian Vac14 and Fig4 that revealed the critical function of PI(3,5)P2 for neuronal survival. A null mutation of Fig4 in the pale tremor mouse results in the formation of vacuoles in the cell bodies of neurons of the central nervous system (CNS) and peripheral nervous system, with extensive degeneration of sensory neurons of the dorsal root ganglia (DRG) and juvenile lethality around the time of weaning (Chow et al, 2007). A null mutation of Vac14 results in perinatal lethality with extensive degeneration of DRG neurons (Zhang et al, 2007). The level of PI(3,5)P2 is reduced by approximately 50% in cultured fibroblasts from both mutants. The increased sensitivity of neurons to mutations causing PI(3,5)P2 deficiency could result from the high rate of membrane turnover required for maintenance of axonal and dendritic processes (Volpicelli-Daley and De Camilli, 2007). Vacuoles that contain the late endosome/lysosome marker LAMP-2 accumulate in cells deficient in Fig4, Vac14 or Fab1 (Ikonomov et al, 2006; Rutherford et al, 2006; Chow et al, 2007; Zhang et al, 2007), suggesting that failure to resolve late endosomal vesicles may be responsible for vacuole accumulation. Human patients who are compound heterozygotes for missense and null mutations of Fig4 are affected by Charcot-Marie-Tooth type 4J, a severe peripheral neuronopathy (Chow et al, 2007; Zhang et al, 2008).
###end p 7
###begin p 8
###xml 4 9 4 9 <italic>ingls</italic>
###xml 138 143 138 143 <italic>et al</italic>
###xml 130 149 130 149 <xref ref-type="bibr" rid="b7">Bronson <italic>et al</italic>, 2003</xref>
###xml 225 230 225 230 <italic>Vac14</italic>
###xml 258 263 258 263 <italic>ingls</italic>
###xml 272 277 272 277 <italic>ingls</italic>
###xml 455 460 455 460 <italic>vac14</italic>
###xml 537 542 537 542 <italic>vac14</italic>
###xml 547 551 547 551 <italic>fab1</italic>
###xml 611 612 611 612 <sub>2</sub>
###xml 1005 1010 1005 1010 <italic>vac14</italic>
###xml 1015 1019 1015 1019 <italic>fab1</italic>
###xml 1083 1084 1083 1084 <sub>2</sub>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
###xml 449 454 <span type="species:ncbi:4932">yeast</span>
###xml 531 536 <span type="species:ncbi:4932">yeast</span>
The ingls mouse, a spontaneous neurological mutant with autosomal recessive inheritance, arose at the Jackson Laboratory in 1991 (Bronson et al, 2003). We now report that a missense mutation of a conserved leucine residue in Vac14 is the molecular defect in ingls. As the ingls mouse survives for up to 3 weeks after birth, postnatal phenotypes caused by defective Vac14 function could be characterized. Examination of the corresponding mutation in yeast vac14, combined with analysis of additional partially functional mutants of yeast vac14 and fab1, led to the determination that Vac14 nucleates the PI(3,5)P2 regulatory complex. The mutants led to the identification of specific regions of the Vac14 protein required for interaction with proteins in the complex. We also demonstrate that two additional regulators of the Fab1 kinase, Vac7p and Atg18p, reside within the complex. We find that formation of the complex is essential for the osmotic-stress-induced activation of Fab1. Analysis of the new vac14 and fab1 mutants provides insights into the organization of the PI(3,5)P2 regulatory complex and its crucial function in the mammalian nervous system.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Phenotype of the ingls mouse
###end title 10
###begin p 11
###xml 25 30 25 30 <italic>ingls</italic>
###xml 200 205 200 205 <italic>ingls</italic>
###xml 218 223 218 223 <italic>ingls</italic>
###xml 340 349 340 349 <xref ref-type="fig" rid="f1">Figure 1A</xref>
###xml 415 434 415 434 <xref ref-type="supplementary-material" rid="S1">Supplementary video</xref>
###xml 571 572 571 572 <italic>P</italic>
###xml 614 625 614 625 <italic>ingls/ingls</italic>
###xml 766 775 766 775 <xref ref-type="fig" rid="f1">Figure 1B</xref>
###xml 948 972 948 972 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S1A</xref>
###xml 1038 1042 1038 1042 <italic>Fig4</italic>
###xml 1060 1065 1060 1065 <italic>et al</italic>
###xml 1055 1071 1055 1071 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 1176 1181 1176 1181 <italic>ingls</italic>
###xml 1190 1214 1190 1214 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S1B</xref>
###xml 1303 1308 1303 1308 <italic>ingls</italic>
###xml 1352 1361 1352 1361 <xref ref-type="fig" rid="f1">Figure 1C</xref>
###xml 1366 1390 1366 1390 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S2A</xref>
###xml 1477 1501 1477 1501 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S2B</xref>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 1048 1053 <span type="species:ncbi:10090">mouse</span>
The spontaneous mutation ingls (infantile gliosis) arose on the DBA/2J strain background and has been maintained by 23 generations of backcrossing to strain C57BL/6J to generate the congenic line B6. ingls. Homozygous ingls mutants exhibit reduced body size and diluted pigmentation that can be recognized as early as postnatal day 3 (P3) (Figure 1A). By P14, the mice exhibit a tremor and impaired motor function (Supplementary video). The frequency of affected offspring born from crosses between heterozygous carriers is consistent with Mendelian expectation (29/140, P=0.24). However, the maximal survival for ingls/ingls homozygotes is 3 weeks, with continuous losses between P1 and P21. Histological analysis of the brain revealed greatly enlarged ventricles (Figure 1B, middle panel). Small areas with the appearance of spongiform degeneration are visible in several brain regions, including the thalamus, brain stem and cerebellar nucleus (Supplementary Figure S1A). This pattern resembles the more widespread degeneration in the Fig4-null mouse (Chow et al, 2007). However, spinal motor neurons and sensory neurons in the DRG remain intact during the lifetime of the ingls mutant (Supplementary Figure S1B). Intense staining for glial fibrillary acidic protein (GFAP) is evident throughout the ingls brain, suggesting widespread astrogliosis (Figure 1C and Supplementary Figure S2A). GFAP is sufficiently increased to be detected by western blot of cortical extracts (Supplementary Figure S2B). Increased GFAP staining is evident as early as E14.5 (not shown).
###end p 11
###begin title 12
Genetic mapping of ingls
###end title 12
###begin p 13
###xml 4 9 4 9 <italic>ingls</italic>
###xml 118 125 118 125 <italic>D8Mit86</italic>
###xml 130 137 130 137 <italic>D8Mit88</italic>
###xml 206 211 206 211 <italic>ingls</italic>
###xml 236 241 236 241 <italic>et al</italic>
###xml 228 247 228 247 <xref ref-type="bibr" rid="b7">Bronson <italic>et al</italic>, 2003</xref>
###xml 403 408 403 408 <italic>ingls</italic>
###xml 434 458 434 458 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S3A</xref>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 517 522 <span type="species:ncbi:10090">Mouse</span>
The ingls mutation was first mapped to an 18 Mb interval on distal mouse chromosome 8, between microsatellite markers D8Mit86 and D8Mit88, by genotyping 31 affected F2 offspring from a cross between DBA/2J.ingls/+ and C57BL/6J (Bronson et al, 2003). Genotyping additional markers on chromosome 8 reduced the nonrecombinant region to a 5.7 Mb interval with the following gene order: SNP1 (111.6 Mb)-1/62-ingls-1/62-D8Mit88 (117.3 Mb) (Supplementary Figure S3A). This nonrecombinant region contains 63 annotated genes (Mouse Build 37.2, ).
###end p 13
###begin title 14
Identification of a mutation in Vac14
###end title 14
###begin p 15
###xml 4 9 4 9 <italic>Vac14</italic>
###xml 87 92 87 92 <italic>ingls</italic>
###xml 150 155 150 155 <italic>ingls</italic>
###xml 188 193 188 193 <italic>Vac14</italic>
###xml 198 202 198 202 <italic>Fig4</italic>
###xml 209 214 209 214 <italic>et al</italic>
###xml 204 220 204 220 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 228 233 228 233 <italic>et al</italic>
###xml 222 239 222 239 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 252 257 252 257 <italic>Vac14</italic>
###xml 282 287 282 287 <italic>ingls</italic>
The Vac14 gene spans the region between 113.1 and 113.2 Mb on chromosome 8, within the ingls nonrecombinant region. Based on similarities between the ingls phenotype and null mutations of Vac14 and Fig4 (Chow et al, 2007; Zhang et al, 2007), we tested Vac14 as a candidate gene for ingls.
###end p 15
###begin p 16
###xml 16 21 16 21 <italic>Vac14</italic>
###xml 69 74 69 74 <italic>ingls</italic>
###xml 235 244 235 244 <xref ref-type="fig" rid="f1">Figure 1D</xref>
###xml 290 295 290 295 <italic>ingls</italic>
###xml 381 384 381 384 <italic>Sac</italic>
###xml 436 441 436 441 <italic>Vac14</italic>
###xml 441 446 441 446 <italic>ingls</italic>
###xml 441 446 441 446 <sup><italic>ingls</italic></sup>
###xml 569 578 569 578 <xref ref-type="fig" rid="f1">Figure 1E</xref>
###xml 685 694 685 694 <xref ref-type="fig" rid="f1">Figure 1F</xref>
The 19 exons of Vac14 were amplified from genomic DNA of an affected ingls homozygote and sequenced. Comparison with the wild-type sequence from strain C57BL/6J (Build 37.2, ) identified the nucleotide substitution c.467T>G in exon 4 (Figure 1D). Strain DBA/2J, the strain of origin of the ingls mutation, contains the wildtype residue (not shown). The T>G substitution destroys a SacI endonuclease site, which was used to genotype the Vac14ingls allele. The mutation results in substitution of an arginine residue for the evolutionarily invariant residue leucine 156 (Figure 1E). Western blot analysis of brain extracts revealed normal abundance of Vac14 protein in the mutant brain (Figure 1F).
###end p 16
###begin title 17
Noncomplementation of ingls and a Vac14-null allele
###end title 17
###begin p 18
###xml 66 71 66 71 <italic>ingls</italic>
###xml 114 119 114 119 <italic>Vac14</italic>
###xml 119 124 119 124 <italic>ingls</italic>
###xml 119 124 119 124 <sup><italic>ingls</italic></sup>
###xml 189 194 189 194 <italic>Vac14</italic>
###xml 194 198 194 195 <italic>&#946;</italic>
###xml 199 202 196 199 <italic>geo</italic>
###xml 194 202 194 199 <sup><italic>&#946;</italic>&#8722;<italic>geo</italic></sup>
###xml 204 209 201 206 <italic>Vac14</italic>
###xml 209 210 206 207 <sup>&#8722;</sup>
###xml 219 224 216 221 <italic>et al</italic>
###xml 213 230 210 227 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 246 251 243 248 <italic>ingls</italic>
###xml 258 263 255 260 <italic>Vac14</italic>
###xml 265 270 262 267 <italic>ingls</italic>
###xml 263 270 260 267 <sup>+/<italic>ingls</italic></sup>
###xml 310 315 307 312 <italic>Vac14</italic>
###xml 315 318 312 315 <sup>+/&#8722;</sup>
###xml 325 330 322 327 <italic>Vac14</italic>
###xml 330 335 327 332 <italic>ingls</italic>
###xml 330 337 327 334 <sup><italic>ingls</italic>/&#8722;</sup>
###xml 456 461 453 458 <italic>ingls</italic>
###xml 495 519 492 516 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S3B</xref>
###xml 581 586 578 583 <italic>ingls</italic>
###xml 648 657 645 654 <xref ref-type="fig" rid="f1">Figure 1A</xref>
###xml 692 701 689 698 <xref ref-type="fig" rid="f1">Figure 1B</xref>
###xml 738 743 735 740 <italic>Vac14</italic>
###xml 743 748 740 745 <italic>ingls</italic>
###xml 743 750 740 747 <sup><italic>ingls</italic>/&#8722;</sup>
###xml 778 783 775 780 <italic>ingls</italic>
###xml 816 821 813 818 <italic>ingls</italic>
###xml 879 884 876 881 <italic>ingls</italic>
###xml 930 935 927 932 <italic>Vac14</italic>
###xml 986 991 983 988 <italic>ingls</italic>
###xml 1126 1131 1123 1128 <italic>Vac14</italic>
###xml 1131 1136 1128 1133 <italic>L156R</italic>
###xml 1131 1136 1128 1133 <sup><italic>L156R</italic></sup>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
To confirm the causal function of the Vac14-L156R mutation in the ingls phenotype, we assessed the ability of the Vac14ingls allele to complement the recessive lethality of the null allele Vac14beta-geo (Vac14-) (Zhang et al, 2007). Heterozygous ingls mice (Vac14+/ingls) were crossed with null heterozygotes (Vac14+/-). The Vac14ingls/- compound heterozygotes were born in the predicted Mendelian ratio of 25% but did not survive to weaning, showing that ingls is allelic with the null allele (Supplementary Figure S3B). The compound heterozygotes reproduced the phenotype of the ingls homozygote, with reduced body size and diluted pigmentation (Figure 1A), as well as enlarged ventricles (Figure 1B). The phenotypic similarity between Vac14ingls/- compound heterozygotes and ingls homozygotes, the failure of the ingls allele to rescue the null homozygote, and the mapping of ingls to an interval of chromosome 8 that includes Vac14, support the identification of Vac14-L156R as the ingls mutation. The survival of the compound heterozygotes to P14, compared with the neonatal lethality of null homozygotes, shows that the Vac14L156R allele retains partial function.
###end p 18
###begin title 19
###xml 26 27 26 27 <sub>2</sub>
Reduced levels of PI(3,5)P2 and vacuolization of cultured ingls fibroblasts
###end title 19
###begin p 20
###xml 60 65 60 65 <italic>ingls</italic>
###xml 113 114 113 114 <sub>2</sub>
###xml 154 159 154 159 <italic>ingls</italic>
###xml 181 182 181 182 <sub>2</sub>
###xml 258 259 258 259 <sub>2</sub>
###xml 277 286 277 286 <xref ref-type="fig" rid="f1">Figure 1G</xref>
Levels of phosphoinositide lipids were assessed in cultured ingls fibroblasts. In wild-type fibroblasts, PI(3,5)P2 comprised 0.04% of total PI. In mutant ingls fibroblasts, PI(3,5)P2 was reduced to 50% of normal, whereas the levels of PI3P, PI4P and PI(4,5)P2 were unaffected (Figure 1G).
###end p 20
###begin p 21
###xml 93 98 93 98 <italic>ingls</italic>
###xml 105 114 105 114 <xref ref-type="fig" rid="f1">Figure 1I</xref>
###xml 158 163 158 163 <italic>ingls</italic>
###xml 211 216 211 216 <italic>Vac14</italic>
###xml 222 226 222 226 <italic>Fig4</italic>
###xml 283 284 283 284 <sub>2</sub>
###xml 325 330 325 330 <italic>et al</italic>
###xml 320 336 320 336 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 344 349 344 349 <italic>et al</italic>
###xml 338 355 338 355 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 477 482 477 482 <italic>ingls</italic>
###xml 510 526 510 526 <xref ref-type="fig" rid="f1">Figure 1H and 1I</xref>
###xml 618 623 618 623 <italic>ingls</italic>
###xml 680 687 680 687 <italic>in vivo</italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 409 414 <span type="species:ncbi:9606">human</span>
There is accumulation of intracellular cytoplasmic vacuoles in the cultured fibroblasts from ingls mice (Figure 1I, bottom). The vacuolated appearance of the ingls fibroblasts is similar to the fibroblasts from Vac14- and Fig4-null mice, indicating that the reduced level of PI(3,5)P2 is responsible for the similarity (Chow et al, 2007; Zhang et al, 2007). Transfection of a construct expressing a wild-type human Vac14-mCit fusion protein reduced the frequency of vacuolized ingls fibroblasts from 20 to 5% (Figure 1H and 1I). Correction by wild-type Vac14 shows that the Vac14-L156R mutation is responsible for the ingls cellular phenotype. The stability of the mutant protein in vivo indicates that the Vac14-L156R protein is functionally impaired.
###end p 21
###begin title 22
Prediction that Vac14 is composed entirely of HEAT repeats places the L156R mutation in repeat 4
###end title 22
###begin p 23
###xml 180 185 180 185 <italic>et al</italic>
###xml 173 191 173 191 <xref ref-type="bibr" rid="b20">Groves <italic>et al</italic>, 1999</xref>
###xml 201 206 201 206 <italic>et al</italic>
###xml 193 212 193 212 <xref ref-type="bibr" rid="b1">Andrade <italic>et al</italic>, 2000</xref>
###xml 290 295 290 295 <italic>et al</italic>
###xml 285 301 285 301 <xref ref-type="bibr" rid="b12">Dove <italic>et al</italic>, 2002</xref>
HEAT repeats contain two anti-parallel helices connected by a short loop. These units often appear as a tandem series and provide surfaces for protein-protein interactions (Groves et al, 1999; Andrade et al, 2000). Previous analysis of the Vac14p sequence identified 1-3 HEAT repeats (Dove et al, 2002). As HEAT repeat sequences are degenerated, many bona fide repeats are not detected by motif detection programs.
###end p 23
###begin p 24
###xml 108 109 108 109 <italic>P</italic>
###xml 109 114 109 110 <sub>&#952;</sub>
###xml 132 137 128 133 <italic>et al</italic>
###xml 124 143 120 139 <xref ref-type="bibr" rid="b1">Andrade <italic>et al</italic>, 2000</xref>
###xml 181 205 177 201 <italic>Saccharomyces cerevisiae</italic>
###xml 270 293 266 289 <italic>Drosophila melanogaster</italic>
###xml 298 323 294 319 <italic>Schizosaccharomyces pombe</italic>
###xml 380 393 376 389 <italic>S. cerevisiae</italic>
###xml 839 852 835 848 <italic>S. cerevisiae</italic>
###xml 861 870 857 866 <xref ref-type="fig" rid="f2">Figure 2A</xref>
###xml 1154 1167 1150 1163 <italic>S. cerevisiae</italic>
###xml 1235 1244 1231 1240 <xref ref-type="fig" rid="f2">Figure 2A</xref>
###xml 1316 1340 1312 1336 <xref ref-type="bibr" rid="b25">Perry and Kleckner, 2003</xref>
###xml 181 205 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 270 293 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 298 323 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 380 393 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 839 852 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 937 942 <span type="species:ncbi:4932">Yeast</span>
###xml 1089 1094 <span type="species:ncbi:9606">human</span>
###xml 1154 1167 <span type="species:ncbi:4932">S. cerevisiae</span>
Analysis of the Vac14 protein sequence with the repeat finding program REP set at a confidence threshold of Ptheta<1e-6 () (Andrade et al, 2000) predicted eight HEAT repeats in the Saccharomyces cerevisiae Vac14p sequence. One additional repeat was identified by REP in Drosophila melanogaster and Schizosaccharomyces pombe sequences and, by sequence similarity, was found in the S. cerevisiae sequence. A second analysis incorporated Vac14p sequences from 17 diverse species. Predicted HEAT repeats were defined by three criteria: (1) identification by REP in one or more species using no confidence threshold; (2) secondary structure prediction of two helices connected by a short loop; (3) alignment by visual inspection with HEAT repeat consensus sequences from the Pfam database. This analysis identified 21 potential HEAT repeats in S. cerevisiae Vac14p (Figure 2A). Many exhibit sequence similarity in all 17 species (not shown). Yeast Vac14p is thus most likely to contain a minimum of 9 HEAT repeats and as many as 21 repeats, which would comprise the entire protein. Analysis of human Vac14 predicted 17 repeats, 15 of which have homologues in S. cerevisiae Vac14p. The L156R mutation is located in helix B of HEAT repeat 4 (Figure 2A). A similar analysis accurately predicted the 50 HEAT repeats of TOR1 (Perry and Kleckner, 2003).
###end p 24
###begin title 25
The L156R mutation disrupts Vac14 interaction with Fab1 but not Fig4
###end title 25
###begin p 26
###xml 90 95 90 95 <italic>et al</italic>
###xml 83 101 83 101 <xref ref-type="bibr" rid="b20">Groves <italic>et al</italic>, 1999</xref>
###xml 111 116 111 116 <italic>et al</italic>
###xml 103 122 103 122 <xref ref-type="bibr" rid="b1">Andrade <italic>et al</italic>, 2000</xref>
###xml 253 254 253 254 <sub>2</sub>
###xml 406 411 406 411 <italic>et al</italic>
###xml 398 417 398 417 <xref ref-type="bibr" rid="b28">Sbrissa <italic>et al</italic>, 2007</xref>
###xml 542 551 542 551 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 558 563 558 563 <italic>ingls</italic>
###xml 683 692 683 692 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 757 762 757 762 <italic>et al</italic>
###xml 752 768 752 768 <xref ref-type="bibr" rid="b12">Dove <italic>et al</italic>, 2002</xref>
###xml 887 896 887 896 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 1007 1012 1007 1012 <italic>ingls</italic>
###xml 463 468 <span type="species:ncbi:4932">yeast</span>
###xml 500 505 <span type="species:ncbi:9606">human</span>
###xml 718 723 <span type="species:ncbi:4932">yeast</span>
###xml 784 789 <span type="species:ncbi:9606">human</span>
HEAT repeat proteins usually function as scaffolds with multiple binding partners (Groves et al, 1999; Andrade et al, 2000). The prediction that Vac14 may be composed entirely of HEAT repeats suggested that Vac14 may bind proteins that regulate PI(3,5)P2 levels. Previous sedimentation and coimmunoprecipitation analysis demonstrated that mammalian Vac14, Fab1, and Fig4 associate with each other (Sbrissa et al, 2007). We tested potential interactions using the yeast two-hybrid test and found that human Vac14 interacts with Fab1 and Fig4 (Figure 2B). The ingls mutation, Vac14-L156R, specifically disrupts the interaction between Vac14 and Fab1 but retains interaction with Fig4 (Figure 2B). A third interaction of yeast Vac14p is self-association (Dove et al, 2002). We find that human Vac14 also interacts with itself and this interaction is unaffected by the Vac14-L156R mutation (Figure 2B). These data suggest that disruption of the interaction between Fab1 and Vac14 is the molecular basis for the ingls mutant phenotype.
###end p 26
###begin title 27
###xml 62 63 62 63 <sub>2</sub>
Vac14p interacts with the known protein regulators of PI(3,5)P2
###end title 27
###begin p 28
###xml 88 89 88 89 <sub>2</sub>
###xml 461 470 461 470 <xref ref-type="fig" rid="f2">Figure 2C</xref>
###xml 560 569 560 569 <xref ref-type="fig" rid="f2">Figure 2C</xref>
###xml 155 160 <span type="species:ncbi:4932">yeast</span>
###xml 222 227 <span type="species:ncbi:4932">yeast</span>
###xml 418 423 <span type="species:ncbi:4932">yeast</span>
###xml 438 443 <span type="species:ncbi:4932">yeast</span>
To determine whether Vac14p interacts with the other proteins known to regulate PI(3,5)P2 levels, we tested Vac7p and Atg18p, two additional regulators of yeast Fab1p. As Fab1p and Vac7p are large proteins, we performed a yeast two-hybrid test with constructs that expressed overlapping peptides from conserved regions of Fab1p and Vac7p. We found that Fab1p peptide 538-1085 and Vac7p peptide 394-918 interacted with yeast Vac14p in the yeast two-hybrid test (Figure 2C). Vac14p also interacts with full-length constructs of Fig4p and Atg18p and with itself (Figure 2C).
###end p 28
###begin p 29
###xml 58 65 58 65 <italic>in vivo</italic>
###xml 333 356 333 356 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S5</xref>
###xml 197 202 <span type="species:ncbi:4932">yeast</span>
To determine whether each protein colocalizes with Vac14p in vivo, we generated a chromosomal integrant of a Vac14p fusion construct containing the fluorescent tag RFP-mCherry. Consistent with the yeast two-hybrid studies, Vac14p-mCherry colocalized on the vacuole membrane with GFP- or Venus-tagged Fab1p, Fig4p, Vac7p, and Atg18p (Supplementary Figure S5).
###end p 29
###begin title 30
Fab1 and its regulators reside within a large protein complex
###end title 30
###begin p 31
###xml 104 113 104 113 <xref ref-type="fig" rid="f2">Figure 2D</xref>
###xml 249 273 249 273 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S4A</xref>
###xml 395 419 395 419 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S4B</xref>
###xml 484 508 484 508 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S4C</xref>
###xml 569 593 569 593 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S4D</xref>
###xml 650 655 650 655 <italic>et al</italic>
###xml 644 661 644 661 <xref ref-type="bibr" rid="b26">Rudge <italic>et al</italic>, 2004</xref>
###xml 671 676 671 676 <italic>et al</italic>
###xml 663 682 663 682 <xref ref-type="bibr" rid="b6">Botelho <italic>et al</italic>, 2008</xref>
###xml 767 772 767 772 <italic>et al</italic>
###xml 759 778 759 778 <xref ref-type="bibr" rid="b6">Botelho <italic>et al</italic>, 2008</xref>
Coimmunoprecitation experiments were performed to test the model that Vac14p nucleates a large complex (Figure 2D). Using the tagged proteins Vac14p-HA and Vac14p-V5, we found that immunoprecipitation with anti-HA antibody coprecipitated Vac14p-V5 (Supplementary Figure S4A). Furthermore, Fab1p containing a C-terminal tandem affinity purification (TAP) tag (Fab1-TAP) coprecipitated Vac14p-V5 (Supplementary Figure S4B). Moreover, immunoprecipitation of Vac14p coprecipitates Fig4p (Supplementary Figure S4C). In addition, precipitation of Fig4p coprecipitates Fab1p (Supplementary Figure S4D). These interactions were reported independently (Rudge et al, 2004; Botelho et al, 2008), and it was proposed that Fab1p, Vac14p, and Fig4p form a ternary complex (Botelho et al, 2008).
###end p 31
###begin p 32
###xml 63 72 63 72 <xref ref-type="fig" rid="f2">Figure 2E</xref>
Immunoprecipitation of Vac14p-Venus also coprecipitates Vac7p (Figure 2E). These coprecipitation experiments demonstrate that Vac14p interacts with itself, Fab1p, Fig4p, and Vac7p. We did not observe coprecipitation of Atg18p with Vac14p, Fab1p-TAP, or Vac7p (not shown).
###end p 32
###begin p 33
###xml 229 238 229 238 <xref ref-type="fig" rid="f2">Figure 2F</xref>
###xml 1124 1129 1124 1129 <italic>et al</italic>
###xml 1116 1135 1116 1135 <xref ref-type="bibr" rid="b6">Botelho <italic>et al</italic>, 2008</xref>
###xml 112 117 <span type="species:ncbi:4932">yeast</span>
To determine whether the proteins form a large complex, we used sedimentation analysis of detergent solubilized yeast cell lysates. When lysates were fractionated on a 10-50% glycerol gradient, Fab1 was distributed in two peaks (Figure 2F). The smaller peak, fraction 3, contained monomeric Fab1p (predicted molecular weight 257 kDa). The larger peak, fractions 6-8, contained Fab1p in a complex that sediments more slowly than the 670 kDa molecular weight standard in fractions 4 and 5. Although the predicted molecular weights of Vac7p, Fig4p, and Vac14p are 128, 101, and 99 kDa, respectively, significant proportions of these proteins comigrated with the large Fab1p complex: Vac7p, in fractions 6 and 7; Fig4p, in fractions 6-8; and Vac14p, in fractions 5-8. That the peak fractions for Fab1p, Vac7p, Fig4p, and Vac14p overlap but are not identical may be explained by the presence of a mixture of partial and complete complexes. For example, the ternary complex of Fab1p, Vac14p, and Fig4p is found exclusively on the membrane of the vacuole, whereas Vac14p and Fig4p associate with each other in the cytosol (Botelho et al, 2008).
###end p 33
###begin p 34
Most of the Atg18p (55 kDa) behaved as a monomer (fractions 1 and 2), but some Atg18p comigrated with the complex (fractions 5-7), suggesting that this small fraction is also part of the complex. Alternatively, the Atg18 in fraction 6 could be trailing from the earlier fractions. However, note that the intensity of fraction 6 is the same as fraction 5. Genetic evidence (below) strongly suggests that a portion of Atg18p is part of the Vac14p complex. Atg18p has a second distinct function in autophagy and the large proportion of monomeric protein may be related to that function.
###end p 34
###begin p 35
The above-mentioned results are consistent with the model that Vac14p nucleates a large complex containing Fab1p, Fig4p, Vac7p, Vac14p, and possibly Atg18p. Rather than pursuing analysis of the complex through further biochemical investigations, we identified and characterized mutations that partially disrupt the complex as a means to determine the functional significance of complete and partial complexes, and also map the interacting domains.
###end p 35
###begin title 36
###xml 63 64 63 64 <sub>2</sub>
Fab1p, Vac14p, and Fig4p are required to form the core PI(3,5)P2 regulatory complex
###end title 36
###begin p 37
###xml 272 282 272 278 <italic>vac14&#916;</italic>
###xml 291 315 287 311 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S4E</xref>
###xml 405 429 401 425 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S4F</xref>
###xml 520 527 516 523 <italic>in vivo</italic>
###xml 688 703 684 699 <xref ref-type="fig" rid="f3">Figure 3A and B</xref>
###xml 732 742 728 734 <italic>vac14&#916;</italic>
###xml 744 753 736 741 <italic>fig4&#916;</italic>
###xml 759 768 747 752 <italic>fab1&#916;</italic>
###xml 40 45 <span type="species:ncbi:4932">yeast</span>
Fab1p does not interact with Fig4p in a yeast two-hybrid test. However, Fab1p-TAP coprecipitates with Fig4p, suggesting that the two proteins could interact indirectly. Indeed, coprecipitation of Fig4p by Fab1p-TAP required the presence of Vac14p and did not occur in the vac14Delta strain (Supplementary Figure S4E). Unexpectedly, coprecipitation of Fab1p-TAP with Vac14p required the presence of Fig4p (Supplementary Figure S4F). These data indicate that Fab1p requires both Vac14p and Fig4p to form a ternary complex in vivo. Localization experiments indicate that formation of the ternary complex is required for normal localization of members of the complex to the vacuole membrane (Figure 3A and B). Note that in each mutant, vac14Delta, fig4Delta, and fab1Delta, there is mislocalization to the cytoplasm of significant amounts of the remaining members of the complex.
###end p 37
###begin p 38
###xml 78 87 78 87 <xref ref-type="fig" rid="f2">Figure 2C</xref>
###xml 231 240 231 236 <italic>vac7&#916;</italic>
###xml 282 306 278 302 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S6A</xref>
###xml 319 343 315 339 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S6B</xref>
###xml 460 484 456 480 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S6C</xref>
###xml 577 601 573 597 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S6C</xref>
###xml 22 27 <span type="species:ncbi:4932">yeast</span>
Vac7p binds Vac14p in yeast two-hybrid and coimmunoprecipitation experiments (Figure 2C and 2E). To determine whether Vac7p is required for formation of the Fab1p/Vac14p/Fig4p complex, we carried out coprecipitation experiments in vac7Delta cells. Interaction of Fab1p with Vac14p (Supplementary Figure S6A) and Fig4p (Supplementary Figure S6B) did not require Vac7p. Localization of Fig4p, Vac14p, and Fab1p to the vacuolar membrane was independent of Vac7p (Supplementary Figure S6C). Similarly, Vac7p localization to the vacuole membrane is independent of Vac14p and Fig4p (Supplementary Figure S6C). Although two-hybrid studies support the proposal that Atg18p is part of the complex, this was not observed by coprecipitation. To further investigate the association of Atg18p with the complex, we examined the effects of Vac14p mutations (below).
###end p 38
###begin title 39
###xml 51 56 <span type="species:ncbi:4932">yeast</span>
The Vac14-ingls mutation disrupts interaction with yeast Fab1p, Vac7p, and Atg18p
###end title 39
###begin p 40
###xml 53 58 53 58 <italic>ingls</italic>
###xml 58 69 58 69 <italic>Vac14&#8211;L156R</italic>
###xml 122 133 122 133 <italic>vac14&#8211;L149R</italic>
###xml 183 192 183 192 <xref ref-type="fig" rid="f4">Figure 4A</xref>
###xml 233 242 233 242 <xref ref-type="fig" rid="f4">Figure 4B</xref>
###xml 249 259 249 255 <italic>vac14&#916;</italic>
###xml 358 367 354 363 <xref ref-type="fig" rid="f4">Figure 4C</xref>
###xml 375 386 371 382 <italic>vac14&#8211;L149R</italic>
###xml 418 423 414 419 <italic>VAC14</italic>
###xml 511 521 507 513 <italic>vac14&#916;</italic>
###xml 572 581 564 573 <xref ref-type="fig" rid="f4">Figure 4C</xref>
###xml 108 113 <span type="species:ncbi:4932">yeast</span>
To further examine the molecular consequences of the inglsVac14-L156R mutation, we generated the equivalent yeast mutant, vac14-L149R. The L149R mutation is located in HEAT repeat 4 (Figure 4A) and does not reduce protein stability (Figure 4B). The vac14Delta mutant has grossly enlarged vacuoles compared with the smaller and multilobed wild-type vacuoles (Figure 4C). When vac14-L149R is present as the sole copy of VAC14, vacuole size and morphology are intermediate between the multilobed wild-type and the vac14Delta mutant, consistent with partial loss of function (Figure 4C).
###end p 40
###begin p 41
###xml 158 167 158 167 <xref ref-type="fig" rid="f4">Figure 4D</xref>
###xml 228 237 228 237 <xref ref-type="fig" rid="f4">Figure 4E</xref>
###xml 321 330 321 330 <xref ref-type="fig" rid="f4">Figure 4F</xref>
###xml 5 10 <span type="species:ncbi:4932">yeast</span>
In a yeast two-hybrid test, vac14p-L149R was defective in binding Fab1p, Vac7p, and Atg18p, although retaining normal interaction with Fig4p and with itself (Figure 4D). vac14p-L149R also failed to coprecipitate with Fab1p-TAP (Figure 4E). In the presence of vac14p-L149R, Fab1p did not localize to the vacuole membrane (Figure 4F). Thus, HEAT repeat 4 is critical for the interaction between Vac14p and Fab1p and is required for the intracellular localization of Fab1p.
###end p 41
###begin p 42
###xml 72 95 72 95 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S7</xref>
In contrast, vac14p-L149R did coprecipitate with Fig4p and with itself (Supplementary Figure S7), indicating that the Fig4p and Vac14p interaction domains are located in a different region of Vac14p from the L149 mutation.
###end p 42
###begin p 43
###xml 56 57 56 57 <sub>2</sub>
###xml 94 101 94 101 <italic>in vivo</italic>
###xml 120 121 120 121 <sub>2</sub>
###xml 155 156 155 156 <sub>2</sub>
###xml 212 222 212 218 <italic>vac14&#916;</italic>
###xml 251 256 247 252 <italic>VAC14</italic>
###xml 328 329 324 325 <sub>2</sub>
###xml 461 470 457 466 <xref ref-type="fig" rid="f4">Figure 4G</xref>
###xml 472 494 468 490 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>
###xml 632 637 628 633 <italic>VAC14</italic>
###xml 704 714 700 706 <italic>vac14&#916;</italic>
###xml 733 744 725 736 <italic>vac14&#8211;L149R</italic>
###xml 754 755 746 747 <sub>2</sub>
###xml 1116 1117 1108 1109 <sub>2</sub>
To examine the effect of loss of Fab1p from the PI(3,5)P2 regulatory complex, we examined the in vivo levels of PI(3,5)P2. Under basal conditions, PI(3,5)P2 comprises approximately 0.04% of total PI lipid in the vac14Delta strain expressing wild-type VAC14 from a plasmid. When cells are exposed to hyperosmotic stress, PI(3,5)P2 increases 10-fold to approximately 0.5% of total PI lipid within 10 min, then decreases to 0.3% at 20 min, and to 0.09% at 30 min (Figure 4G, Supplementary Table S1). (The 10-fold increase in this wild-type strain compared with a more typical 20-fold increase may be a consequence of the expression of VAC14 from a plasmid rather than from its chromosomal location.) In the vac14Delta strain expressing vac14-L149R, PI(3,5)P2 comprises 0.03% of the PI lipid under basal conditions and increases only two-fold to 0.06% after 10 min of hyperosmotic stress. Thus, dissociation of Fab1p from the complex through loss of interaction between Vac14p and Fab1p results in defective activation of Fab1 lipid kinase activity in response to hyperosmotic shock. That the modest increase in PI(3,5)P2 is sustained for at least 30 min suggests that regulation of Fig4p lipid phosphatase activity may also be impaired by the loss of association of Fab1p and Vac14p.
###end p 43
###begin title 44
The fab1-2 mutant reveals that activation of Fab1p requires its association with the Vac14p complex
###end title 44
###begin p 45
###xml 105 111 105 111 <italic>fab1-2</italic>
###xml 129 134 129 134 <italic>et al</italic>
###xml 120 140 120 140 <xref ref-type="bibr" rid="b31">Yamamoto <italic>et al</italic>, 1995</xref>
###xml 213 219 213 219 <italic>fab1-2</italic>
###xml 290 299 290 299 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 331 338 331 338 <italic>in vivo</italic>
###xml 340 349 340 349 <xref ref-type="fig" rid="f5">Figure 5B</xref>
###xml 386 394 386 394 <italic>in vitro</italic>
###xml 396 419 396 419 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S8</xref>
###xml 704 713 704 713 <xref ref-type="fig" rid="f2">Figure 2C</xref>
###xml 718 720 718 720 <xref ref-type="fig" rid="f5">5C</xref>
###xml 844 854 844 854 <italic>fab1&#8211;G864E</italic>
###xml 878 883 878 883 <italic>VAC14</italic>
###xml 885 894 885 894 <xref ref-type="fig" rid="f5">Figure 5C</xref>
###xml 990 999 990 999 <xref ref-type="fig" rid="f5">Figure 5D</xref>
###xml 681 686 <span type="species:ncbi:4932">yeast</span>
###xml 821 826 <span type="species:ncbi:4932">yeast</span>
We sought to identify a mutation in Fab1p that disrupted its interaction with Vac14p, and found that the fab1-2 mutant (Yamamoto et al, 1995) is specifically defective in this interaction. We sequenced the mutant fab1-2, and identified a single missense mutation, G864E, in the CCT domain (Figure 5A). The mutant protein is stable in vivo (Figure 5B) and retains normal kinase activity in vitro (Supplementary Figure S8). The CCT domain of Fab1p shares homology with the GroEL and the CCT family of Hsp60 chaperones, suggesting that it could be involved in protein-protein interactions. The G864E mutation is located within Fab1p peptide 538-1085, which interacts with Vac14p in a yeast two-hybrid test (Figure 2C and 5C). We therefore tested the effect of this mutation on the interaction between Fab1 and Vac14. In the yeast two-hybrid test, fab1-G864E does not interact with VAC14 (Figure 5C). Wild-type Fab1p coimmunoprecipitates with Vac14p-Venus, but the Fab1p-G864E mutant does not (Figure 5D). Thus, the G864E mutation disrupts interaction of Fab1p with Vac14p.
###end p 45
###begin p 46
###xml 45 54 45 54 <xref ref-type="fig" rid="f5">Figure 5E</xref>
###xml 138 147 138 147 <xref ref-type="fig" rid="f5">Figure 5E</xref>
###xml 279 309 279 309 <xref ref-type="supplementary-material" rid="S1">Supplementary Figure S4E and F</xref>
###xml 440 445 440 445 <italic>et al</italic>
###xml 432 451 432 451 <xref ref-type="bibr" rid="b6">Botelho <italic>et al</italic>, 2008</xref>
Fab1p coimmunoprecipitates with Fig4p-3XGFP (Figure 5E). However, the Fab1p-G864E mutant protein does not coprecipitate with Fig4p-3XGFP (Figure 5E). This further supports the model that interaction of Fab1p with Fig4p is dependent on interaction of Fab1p and Fig4p with Vac14p (Supplementary Figure S4E and F). These coprecipitation results are similar to those observed for fab1p-T1017I, another point mutation in the CCT domain (Botelho et al, 2008).
###end p 46
###begin p 47
###xml 69 78 69 78 <xref ref-type="fig" rid="f5">Figure 5F</xref>
###xml 205 214 205 214 <xref ref-type="fig" rid="f5">Figure 5F</xref>
The fab1-2 mutant protein fails to localize to the vacuole membrane (Figure 5F). Localizations of Vac14p-Venus and Fig4p-3xGFP to the vacuole membrane are also defective in the presence of fab1-2 protein (Figure 5F). Formation of the ternary complex thus appears to be required for correct localization of each component.
###end p 47
###begin p 48
###xml 171 172 171 172 <sub>2</sub>
###xml 187 193 187 193 <italic>fab1-2</italic>
###xml 255 256 255 256 <sub>2</sub>
###xml 404 413 404 413 <xref ref-type="fig" rid="f5">Figure 5G</xref>
###xml 415 437 415 437 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>
###xml 447 453 447 453 <italic>fab1-2</italic>
###xml 490 491 490 491 <sub>2</sub>
###xml 554 564 554 564 <italic>vac14&#8211;L149</italic>
###xml 773 774 773 774 <sub>2</sub>
To determine the importance of formation of the ternary complex for the hyperosmotic stress-induced activation of Fab1p, we tested the effect of osmotic stress on PI(3,5)P2 levels in the fab1-2 mutant. In the wild-type strain, the basal levels of PI(3,5)P2, 0.05% of total PI lipid, increase 20-fold to 1.15% within 10 min after hyperosmotic stress, then decrease to 0.32% at 20 min and 0.11% at 30 min (Figure 5G, Supplementary Table S1). In the fab1-2 mutant, the basal levels of PI(3,5)P2, 0.033%, increased only two-fold after 10 min, similar to the vac14-L149 mutant described above. These data support the conclusion that association with the complex is required for the hyperosmotic stress-induced activation of Fab1p and for the physiological regulation of PI(3,5)P2 levels.
###end p 48
###begin title 49
The vac14-2 mutant disrupts interaction with Vac7p and Atg18p and results in defective activation and inhibition of Fab1p
###end title 49
###begin p 50
###xml 71 72 71 72 <sub>2</sub>
###xml 104 113 104 109 <italic>vac7&#916;</italic>
###xml 166 171 162 167 <italic>et al</italic>
###xml 154 177 150 173 <xref ref-type="bibr" rid="b4">Bonangelino <italic>et al</italic>, 1997</xref>
###xml 184 189 180 185 <italic>et al</italic>
###xml 179 196 175 192 <xref ref-type="bibr" rid="b15">Duex <italic>et al</italic>, 2006b</xref>
###xml 296 297 292 293 <sub>2</sub>
###xml 334 343 330 335 <italic>vac7&#916;</italic>
###xml 377 382 369 374 <italic>VAC14</italic>
###xml 437 458 429 442 <italic>vac14&#916;, vac7&#916;</italic>
###xml 608 615 586 593 <italic>vac14-2</italic>
###xml 636 646 614 620 <italic>vac14&#916;</italic>
###xml 705 714 679 688 <xref ref-type="fig" rid="f6">Figure 6A</xref>
###xml 741 742 715 716 <sub>2</sub>
###xml 860 861 834 835 <sub>2</sub>
###xml 869 876 843 850 <italic>vac14-2</italic>
###xml 885 894 859 868 <xref ref-type="fig" rid="f6">Figure 6B</xref>
###xml 896 918 870 892 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>
###xml 939 946 913 920 <italic>vac14-2</italic>
###xml 1013 1014 987 988 <sub>2</sub>
###xml 1098 1107 1072 1081 <xref ref-type="fig" rid="f6">Figure 6B</xref>
###xml 1200 1209 1174 1183 <xref ref-type="fig" rid="f6">Figure 6C</xref>
###xml 1247 1248 1221 1222 <sub>2</sub>
###xml 30 35 <span type="species:ncbi:4932">yeast</span>
Vac7p is a major activator of yeast Fab1p, and basal levels of PI(3,5)P2 are significantly reduced in a vac7Delta mutant, resulting in enlarged vacuoles (Bonangelino et al, 1997; Duex et al, 2006b). We screened for gain-of-function mutations of Vac14p that could rescue the low levels of PI(3,5)P2 and reduce the enlarged vacuoles in vac7Delta cells. Random PCR mutagenesis of VAC14 was performed and the mutants were transformed into a vac14Delta, vac7Delta strain. Mutants that restored growth at 37degreesC and partially corrected the enlarged vacuoles were isolated. When the strongest of these mutants, vac14-2, was expressed in a vac14Delta strain, vacuole size was smaller than in wild-type cells (Figure 6A), suggesting that PI(3,5)P2 level is increased in this mutant. Direct measurement demonstrated a two-fold increase of the basal level of PI(3,5)P2 in the vac14-2 mutant (Figure 6B, Supplementary Table S1). However, when the vac14-2 mutant was treated with hyperosmotic stress, the level of PI(3,5)P2 increased only 1.7-fold, compared with an 8-fold increase in the wild-type strain (Figure 6B). There was no change in the steady-state level of vac14-2 protein compared with wild type (Figure 6C). The abnormal regulation of PI(3,5)P2 thus appears to be caused by altered function of the vac14-2 protein.
###end p 50
###begin p 51
###xml 28 36 28 36 <italic>vac14 -2</italic>
###xml 101 110 101 110 <xref ref-type="fig" rid="f6">Figure 6D</xref>
###xml 322 331 322 331 <xref ref-type="fig" rid="f6">Figure 6E</xref>
###xml 5 10 <span type="species:ncbi:4932">yeast</span>
In a yeast two-hybrid test, vac14 -2 is specifically defective in interaction with Vac7p and Atg18p (Figure 6D). Interaction of vac14-2 protein with Vac14p, Fig4p, and Fab1p is normal and formation of the ternary complex is unaffected. The vac14-2 protein also coprecipitates Fab1p to the same extent as wild-type Vac14p (Figure 6E).
###end p 51
###begin p 52
###xml 0 7 0 7 <italic>vac14-2</italic>
###xml 63 72 63 72 <xref ref-type="fig" rid="f6">Figure 6F</xref>
###xml 232 237 <span type="species:ncbi:4932">yeast</span>
vac14-2 contains four mutations: H56Y, R61K, Q101R, and L329I (Figure 6F). Three of these mutations, H56, R61, and Q101, are located in HEAT repeat loops 2 and 3. These residues exhibit evolutionary conservation. Tested singly in a yeast two-hybrid test, each mutation perturbed the interaction of Vac14p with Vac7p and Atg18p, without disrupting interaction with its other binding partners (not shown). Thus all three residues are important for Vac14p interaction with Vac7p and Atg18p. L329 alone had no effect on the interaction of Vac14p with its known binding partners (data not shown). These results indicate that HEAT repeats 2 and 3 directly contact Vac7p and Atg18p, but do not contact Fab1.
###end p 52
###begin p 53
###xml 41 42 41 42 <sub>2</sub>
###xml 50 57 50 57 <italic>vac14-2</italic>
###xml 428 429 428 429 <sub>2</sub>
###xml 515 522 515 522 <italic>vac14-2</italic>
###xml 188 193 <span type="species:ncbi:4932">yeast</span>
The elevation in basal levels of PI(3,5)P2 in the vac14-2 mutant is consistent with the model that negative regulation of Fab1p by Atg18p requires binding of Atg18p to Vac14p. Whereas the yeast two-hybrid test detected interaction of Atg18p with Vac14p, this was not observed in pull-down experiments. Thus, it is informative that a mutation in Vac14p that interrupts its ability to interact with Atg18p also results in PI(3,5)P2 levels that are consistent with a partial release of Atg18p inhibition of Fab1p. The vac14-2 mutant provides additional support for the hypothesis that Atg18p interacts with Vac14p.
###end p 53
###begin p 54
###xml 4 11 4 11 <italic>vac14-2</italic>
###xml 66 67 66 67 <sub>2</sub>
###xml 296 308 296 308 <xref ref-type="fig" rid="f2">Figure 2C, E</xref>
###xml 244 249 <span type="species:ncbi:4932">yeast</span>
The vac14-2 defect in osmotic stress-induced elevation of PI(3,5)P2 supports the model that Vac7p, a positive regulator of Fab1p, exert an effect through binding to Vac14p. The association of Vac7p with wild-type Vac14p was demonstrated in the yeast two-hybrid test and by coimmunoprecipitation (Figure 2C, E).
###end p 54
###begin title 55
The Fig4p-binding site on Vac14p is distinct from the Fab1p-, Vac7p-, and Atg18p-binding sites
###end title 55
###begin p 56
###xml 161 169 161 169 <xref ref-type="fig" rid="f7">Figure 7</xref>
Fab1p and Vac7p bind near the N terminus of Vac14p. On the basis of the predicted HEAT motifs of Vac14p, we divided the protein into two overlapping constructs (Figure 7). HEAT repeats 1-10 interact with Fab1p and Vac7p but not with Fig4p. HEAT repeats 10-21 interact only with Fig4p. These results demonstrate that Fab1p and Vac7p bind to the N-terminal half of Vac14p, whereas Fig4p binds to a distinct site in the C-terminal half. Atg18p binds full-length Vac14p but does not bind to either half of the molecule. On the basis of the vac14-2 mutant, we predict that contact points for Atg18p include the intrarepeat loops of HEAT repeats 2 and 3.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 211 216 211 216 <italic>et al</italic>
###xml 203 222 203 222 <xref ref-type="bibr" rid="b6">Botelho <italic>et al</italic>, 2008</xref>
###xml 389 393 389 393 <italic>fab1</italic>
###xml 398 403 398 403 <italic>vac14</italic>
###xml 764 765 764 765 <sub>2</sub>
###xml 1243 1244 1243 1244 <sub>2</sub>
###xml 1432 1437 1432 1437 <italic>et al</italic>
###xml 1427 1444 1427 1444 <xref ref-type="bibr" rid="b15">Duex <italic>et al</italic>, 2006b</xref>
###xml 183 188 <span type="species:ncbi:4932">yeast</span>
###xml 433 438 <span type="species:ncbi:4932">yeast</span>
###xml 1032 1037 <span type="species:ncbi:4932">yeast</span>
Here, we present support for the model that Fab1, Vac14, and Fig4 form a ternary complex. While this article was in preparation, independent evidence for formation of this complex in yeast was reported (Botelho et al, 2008). Our present studies significantly extend those studies by our discovery that the complex is nucleated by Vac14. Moreover, analysis of the new, partially functional fab1 and vac14 mutants demonstrate that the yeast complex includes Vac7p, a positive regulator of Fab1p, and is most likely to include Atg18p, an inhibitor of Fab1p. We find that both Vac7p and Atg18p exert an effect through direct contact with Vac14p. Our analysis strongly suggests that the organization of the complex produces dynamic, stimulus-induced changes in PI(3,5)P2, by three distinct mechanisms. First, the activator Vac7p and the inhibitor Atg18p bind to overlapping sites, close to the site of Fab1p. This arrangement could facilitate the rapid activation and inactivation of the Fab1p lipid kinase during hyperosmotic stress in yeast. Second, Fab1p and Fig4p bind simultaneously to nonoverlapping sites on Vac14p, bring them into close proximity, so that the lipid kinase and phosphatase share access to the same pools of PI3P and PI(3,5)P2. Third, the close proximity of Fab1p and Fig4p is also consistent with our earlier postulate that Fig4p may function as a protein phosphatase to activate Fab1p by dephosphorylation (Duex et al, 2006b).
###end p 58
###begin title 59
Vac14 contains multiple HEAT repeats
###end title 59
###begin p 60
###xml 45 50 45 50 <italic>ingls</italic>
###xml 442 447 442 447 <italic>et al</italic>
###xml 435 453 435 453 <xref ref-type="bibr" rid="b20">Groves <italic>et al</italic>, 1999</xref>
###xml 460 465 460 465 <italic>et al</italic>
###xml 455 471 455 471 <xref ref-type="bibr" rid="b30">Xing <italic>et al</italic>, 2006</xref>
###xml 499 505 499 505 <italic>vac14-</italic>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 189 194 <span type="species:ncbi:4932">yeast</span>
The partial loss of function of Vac14 in the ingls mouse prompted us to evaluate the molecular function of this uncharacterized protein. Our bioinformatics analysis predicted that both the yeast and mammalian Vac14 proteins are composed entirely of HEAT repeats. Tandem HEAT repeats form a super-helical structure that provides docking sites for other proteins. The most common protein-protein docking sites are the intrarepeat loops (Groves et al, 1999; Xing et al, 2006). Three point mutations in vac14-2 that impair protein interaction are located in predicted intrarepeat loops, R61K and H56Y in HEAT 2 and Q101R in HEAT 3. The location in the intrarepeat loops of three, random independent mutations that alter protein interactions supports the prediction of the HEAT repeat structure of Vac14. Analysis of the vac14-2 mutant also indicates that Vac7p and Atg18p bind overlapping sites that include the intrarepeat loops of HEAT repeats 2 and 3.
###end p 60
###begin p 61
###xml 106 128 106 128 <xref ref-type="bibr" rid="b8">Chook and Blobel, 1999</xref>
###xml 140 145 140 145 <italic>et al</italic>
###xml 130 151 130 151 <xref ref-type="bibr" rid="b10">Cingolani <italic>et al</italic>, 1999</xref>
###xml 232 237 232 237 <italic>ingls</italic>
A second potential protein-protein interaction site is on a face formed by the B helices of HEAT repeats (Chook and Blobel, 1999; Cingolani et al, 1999). The helices provide both structure and points of protein-protein contact. The ingls mutation is located on the predicted B helix of HEAT 4. This mutation affects the binding of Fab1p and also impairs binding of Atg18p and Vac7p. The Fab1p-, Atg18p-, and Vac7p-binding sites may overlap, or the vac14-L149R mutation may perturb the surrounding structure, altering the Fab1p-binding site and a separate Atg18p/Vac7p-binding site. The overlap of Atg18p and Vac7p sites at a position close to the Fab1p-binding site is consistent with competitive regulation of Fab1p by its positive and negative regulators.
###end p 61
###begin title 62
Vac14 is a scaffold for the Fab1 kinase complex
###end title 62
###begin p 63
###xml 190 191 190 191 <sub>2</sub>
###xml 213 224 213 224 <italic>vac14&#8211;L149R</italic>
###xml 229 236 229 236 <italic>vac14-2</italic>
###xml 466 474 466 474 <xref ref-type="fig" rid="f7">Figure 7</xref>
###xml 549 557 549 557 <xref ref-type="fig" rid="f7">Figure 7</xref>
###xml 736 737 736 737 <sub>2</sub>
###xml 374 379 <span type="species:ncbi:4932">yeast</span>
As HEAT repeats mediate protein-protein interactions, we investigated and found that Vac14p nucleates the assembly of a complex containing the proteins that synthesize and turn over PI(3,5)P2. The location of the vac14-L149R and vac14-2 mutations near the N-terminal region of Vac14p indicates that the N-terminal half of Vac14p binds Fab1p, Vac7p, and Atg18p. Indeed, in a yeast two-hybrid test, HEAT repeats 1-10 of Vac14p were sufficient to bind Fab1p and Vac7p (Figure 7). Conversely, HEAT repeats 10-21 of Vac14p were sufficient to bind Fig4p (Figure 7). Thus, Fab1p, Fig4p, and two additional Fab1p regulatory proteins all directly contact Vac14p and make a large complex that regulates both the synthesis and turnover of PI(3,5)P2.
###end p 63
###begin title 64
###xml 31 32 31 32 <sub>2</sub>
###xml 94 95 94 95 <sub>2</sub>
The composition of the PI(3,5)P2 regulatory complex facilitates dynamic regulation of PI(3,5)P2
###end title 64
###begin p 65
###xml 4 10 4 10 <italic>fab1-2</italic>
###xml 394 402 394 402 <xref ref-type="fig" rid="f8">Figure 8</xref>
###xml 785 786 785 786 <sub>2</sub>
###xml 807 812 807 812 <italic>et al</italic>
###xml 795 818 795 818 <xref ref-type="bibr" rid="b4">Bonangelino <italic>et al</italic>, 1997</xref>
###xml 825 830 825 830 <italic>et al</italic>
###xml 820 837 820 837 <xref ref-type="bibr" rid="b15">Duex <italic>et al</italic>, 2006b</xref>
The fab1-2 mutation disrupts the ability of Fab1p to interact with Vac14p and prevents coprecipitation of Fab1p with Fig4p. Negative two-hybrid test results (not shown) suggest that Fab1p and Fig4p do not interact directly. Fab1p binds to the N terminus and Fig4p binds to the C terminus of Vac14p. We propose that Vac14p assumes a conformation that brings Fab1p into close proximity to Fig4p (Figure 8). This physical proximity may explain our previous evidence that the lipid phosphatase Fig4p is an activator of the Fab1p kinase, possibly through dephosphorylation of the Fab1 protein. Importantly, the phosphatase activity of Fig4p is required for its regulatory function; an active site mutant that retains interaction with Vac14p is nonetheless defective in elevation of PI(3,5)P2 levels (Bonangelino et al, 1997; Duex et al, 2006b). Fig4p may also contribute to Fab1p activation through stabilization of the regulatory complex.
###end p 65
###begin p 66
###xml 72 73 72 73 <sub>2</sub>
###xml 161 162 161 162 <sub>2</sub>
###xml 318 319 318 319 <sub>2</sub>
###xml 327 334 327 334 <italic>in vivo</italic>
###xml 341 346 341 346 <italic>et al</italic>
###xml 336 353 336 353 <xref ref-type="bibr" rid="b14">Duex <italic>et al</italic>, 2006a</xref>
In addition to both the lipid phosphatase and lipid kinase, the PI(3,5)P2 regulatory complex includes a second pair of proteins with opposing effects on PI(3,5)P2 levels: a lipid kinase activator and inhibitor. The close association of each of these proteins in a complex may be key to the rapid modulation of PI(3,5)P2 levels in vivo (Duex et al, 2006a).
###end p 66
###begin p 67
###xml 114 115 114 115 <sub>2</sub>
###xml 414 415 414 415 <sub>2</sub>
###xml 964 965 964 965 <sub>2</sub>
Identification of the components of the Vac14p complex provides new insights into the acute regulation of PI(3,5)P2 levels. First, the Fab1p lipid kinase and Fig4p lipid phosphatase reside in the same complex and bind to opposite ends of Vac14p. A conformational change in Vac14p could simultaneously affect the activities of the kinase and phosphatase in opposite directions, amplifying the net effect on PI(3,5)P2. Second, the complex contains both an activator and an inhibitor of Fab1p, Vac7p, and Atg18p, respectively, which bind to the same region of Vac14p, and most likely bind close to Fab1p. Again, an altered conformation of Vac14p could result in opposite effects on binding of the two proteins, amplifying the effect of either one alone on Fab1p activity. Third, Fig4p has a dual function and is both a lipid phosphatase and an activator of the lipid kinase. The structure of the protein complex is most likely to facilitate the rapid flux in PI(3,5)P2 levels that occurs in response to various biological stimuli.
###end p 67
###begin title 68
###xml 8 9 8 9 <sub>2</sub>
PI(3,5)P2 is required for neural function and pigmentation
###end title 68
###begin p 69
###xml 39 43 39 43 <italic>Fig4</italic>
###xml 48 53 48 53 <italic>Vac14</italic>
###xml 60 65 60 65 <italic>et al</italic>
###xml 55 71 55 71 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 79 84 79 84 <italic>et al</italic>
###xml 73 90 73 90 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 97 102 97 102 <italic>Vac14</italic>
###xml 103 108 103 108 <italic>ingls</italic>
###xml 169 170 169 170 <sub>2</sub>
###xml 246 251 246 251 <italic>Vac14</italic>
###xml 382 387 382 387 <italic>ingls</italic>
###xml 518 523 518 523 <italic>Vac14</italic>
###xml 865 870 865 870 <italic>ingls</italic>
###xml 948 949 948 949 <sub>2</sub>
###xml 974 979 974 979 <italic>ingls</italic>
###xml 1047 1048 1047 1048 <sub>2</sub>
###xml 1134 1139 1134 1139 <italic>ingls</italic>
###xml 1207 1208 1207 1208 <sub>2</sub>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 257 262 <span type="species:ncbi:10090">mouse</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 388 393 <span type="species:ncbi:10090">mouse</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 801 806 <span type="species:ncbi:4932">yeast</span>
###xml 980 985 <span type="species:ncbi:10090">mouse</span>
###xml 1140 1145 <span type="species:ncbi:10090">mouse</span>
Similar to the null mutations of mouse Fig4 and Vac14 (Chow et al, 2007; Zhang et al, 2007), the Vac14-ingls mutation results in reduced intracellular levels of PI(3,5)P2, cytoplasmic vacuolization, neurodegeneration, and early lethality. As the Vac14-null mouse dies perinatally, defects in nervous system function were inferred solely from the histopathology of newborn mice. The ingls mouse lives up to 3 weeks, permitting direct observation of abnormal neurological function, pigmentation, and growth defects. The Vac14-ingls mice develop a tremor and motor incoordination exemplified by ataxic gait and difficulty in righting. Although the steady-state levels of Vac14-ingls protein are normal and interaction with Fig4 is retained, binding of Fab1 is abolished. The failure of the corresponding yeast mutant to activate Fab1 strongly suggests that failure of ingls Vac14-L156R to activate mammalian Fab1 accounts for the low level of PI(3,5)P2 in fibroblasts from the ingls mouse. The data suggest that dissociation of Fab1 from the PI(3,5)P2 regulatory complex is the molecular basis for neurodegeneration and lethality in the ingls mouse. Thus, the ability of Vac14 to nucleate the complete PI(3,5)P2 regulatory complex is essential for normal neural function.
###end p 69
###begin p 70
###xml 24 29 24 29 <italic>Vac14</italic>
###xml 37 42 37 42 <italic>Vac14</italic>
###xml 52 56 52 56 <italic>Fig4</italic>
###xml 81 103 81 103 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S2</xref>
###xml 146 150 146 150 <italic>Fig4</italic>
###xml 156 161 156 161 <italic>Vac14</italic>
###xml 195 200 195 200 <italic>Vac14</italic>
###xml 201 206 201 206 <italic>ingls</italic>
###xml 314 315 314 315 <sub>2</sub>
###xml 379 390 379 390 <italic>Vac14&#8211;ingls</italic>
###xml 561 566 561 566 <italic>ingls</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
Differences between the Vac14-ingls, Vac14-null and Fig4-null mice are listed in Supplementary Table S2. DRG neurons are severely affected in the Fig4- and Vac14-null mice, but are spared in the Vac14-ingls mutant. This rescue of sensory neurons may be explained by their greater capacity for synthesis of PI(3,5)P2, or by a higher abundance of downstream effector proteins. The Vac14-ingls mutant exhibits astrocytosis with earlier onset and greater severity than the other mutants, which merits further investigation. Hydrocephalus is also more severe in the ingls mice, with huge distention of the ventricles. Differences in the abundance of interacting proteins may account for the cell-type-specific effects of these mutations. The mixed-strain backgrounds of the two null mutants may also contribute to phenotypic differences from the congenic C57BL/6J.ingls mice discussed here.
###end p 70
###begin title 71
###xml 19 20 19 20 <sub>2</sub>
###xml 36 41 <span type="species:ncbi:9606">human</span>
Defects of PI(3,5)P2 regulation and human disease
###end title 71
###begin p 72
###xml 19 23 19 23 <italic>FIG4</italic>
###xml 127 131 127 131 <italic>Fig4</italic>
###xml 149 154 149 154 <italic>et al</italic>
###xml 144 160 144 160 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 197 202 197 202 <italic>Vac14</italic>
###xml 328 333 328 333 <italic>VAC14</italic>
###xml 385 390 385 390 <italic>VAC14</italic>
###xml 517 522 517 522 <italic>VAC14</italic>
###xml 558 562 558 562 <italic>SCA4</italic>
###xml 625 630 625 630 <italic>VAC14</italic>
###xml 646 651 646 651 <italic>et al</italic>
###xml 637 657 637 657 <xref ref-type="bibr" rid="b17">Flanigan <italic>et al</italic>, 1996</xref>
###xml 686 691 686 691 <italic>VAC14</italic>
###xml 730 734 730 734 <italic>SCA4</italic>
###xml 875 880 875 880 <italic>VAC14</italic>
###xml 1003 1007 1003 1007 <italic>GFAP</italic>
###xml 1029 1034 1029 1034 <italic>VAC14</italic>
###xml 1038 1042 1038 1042 <italic>FIG4</italic>
###xml 1136 1141 1136 1141 <italic>ingls</italic>
###xml 1216 1221 1216 1221 <italic>VAC14</italic>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 303 311 <span type="species:ncbi:9606">patients</span>
###xml 530 535 <span type="species:ncbi:9606">human</span>
###xml 894 899 <span type="species:ncbi:9606">human</span>
###xml 946 954 <span type="species:ncbi:9606">patients</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
###xml 1258 1263 <span type="species:ncbi:9606">human</span>
Mutations of human FIG4 result in the peripheral neuropathy Charcot-Marie-Tooth type 4J, with features similar to those in the Fig4-null mouse (Chow et al, 2007). To determine whether mutations of Vac14 could contribute to Charcot-Marie-Tooth disorder, we screened the previously described cohort of 95 patients for variants of VAC14. No variants in coding sequence or splice sites of VAC14 were observed (C Chow, M Meisler, M Khajavi, K Szigeti and JR Lupski, unpublished data). We also investigated the function of VAC14 in the human neurological disorder SCA4, which maps to a region of chromosome 16q22 that contains the VAC14 gene (Flanigan et al, 1996). We sequenced the exons of VAC14 in an affected member of the original SCA4 family, but did not detect any coding or splice site mutations (C Chow, M Meisler, and Y-H Fu, unpublished data). Thus, the contribution of VAC14 mutations to human disease remains unknown. Extensive gliosis in patients with Alexander disease is caused by mutation of GFAP; it is possible that VAC14 or FIG4 could contribute to other disorders characterized by gliosis. The lack of DRG defects in the ingls mice, in contrast to the previously described null mutants, suggests that VAC14 could have an important function in human neurological disorders that are restricted to the CNS and have not yet been tested.
###end p 72
###begin title 73
###xml 37 38 37 38 <sub>2</sub>
Evolutionary conservation of PI(3,5)P2 regulation
###end title 73
###begin p 74
###xml 100 105 100 105 <italic>ingls</italic>
###xml 331 332 331 332 <sub>2</sub>
###xml 408 416 408 416 <xref ref-type="fig" rid="f8">Figure 8</xref>
###xml 509 514 509 514 <italic>ingls</italic>
###xml 537 542 537 542 <italic>ingls</italic>
###xml 627 638 627 638 <italic>vac14&#8211;ingls</italic>
###xml 981 982 981 982 <sub>2</sub>
###xml 1044 1045 1044 1045 <sub>2</sub>
###xml 1121 1125 1121 1125 <italic>Fig4</italic>
###xml 1130 1135 1130 1135 <italic>Vac14</italic>
###xml 1142 1147 1142 1147 <italic>et al</italic>
###xml 1137 1153 1137 1153 <xref ref-type="bibr" rid="b9">Chow <italic>et al</italic>, 2007</xref>
###xml 1161 1166 1161 1166 <italic>et al</italic>
###xml 1155 1172 1155 1172 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 1221 1225 1221 1225 <italic>FAB1</italic>
###xml 1359 1360 1359 1360 <sub>2</sub>
###xml 1414 1415 1414 1415 <sub>2</sub>
###xml 39 44 <span type="species:ncbi:4932">yeast</span>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
###xml 200 205 <span type="species:ncbi:4932">yeast</span>
###xml 360 365 <span type="species:ncbi:4932">yeast</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 616 621 <span type="species:ncbi:4932">yeast</span>
###xml 1215 1220 <span type="species:ncbi:9606">human</span>
###xml 1463 1468 <span type="species:ncbi:9606">human</span>
Our study used the cognate mutation in yeast to provide molecular insight into the pathology of the ingls mouse. This work indicates that the activation of Fab1 by the Vac14 complex is conserved from yeast to mammals and is essential for nervous tissue function, pigmentation and viability. Vac14 nucleates assembly of the PI(3,5)P2 core regulatory complex in yeast and serves as a scaffold for the complex (Figure 8). Loss of interaction between Vac14 and Fab1 results in the lethal neurological disorder in ingls mice. Analysis of the ingls mutation enabled us to localize the Fab1-interaction domain of Vac14. In yeast, the vac14-ingls mutation also disrupts interaction with Vac7p, a positive regulator of Fab1p, and Atg18p, a negative regulator. The mammalian homologue of Vac7p has not been identified, whereas four distinct homologues of Atg18p are present in the mammalian genome: WIPI 1-4. Further work will be required to identify all components of the mammalian PI(3,5)P2 regulatory complex and to determine the functions of PI(3,5)P2. Thus far, we have described pathological mutations in the core components Fig4 and Vac14 (Chow et al, 2007; Zhang et al, 2007; this article). Heterozygous mutations of human FAB1 cause the mild eye phenotype corneal fleck dystrophy (OMIM 609414). In view of the vulnerability of neurons to alteration of PI(3,5)P2 levels, mutations in other components of the PI(3,5)P2 regulatory complex are likely to contribute to human neurological disease.
###end p 74
###begin title 75
Materials and methods
###end title 75
###begin title 76
Animals
###end title 76
###begin p 77
###xml 4 9 4 9 <italic>ingls</italic>
###xml 385 390 385 390 <italic>et al</italic>
###xml 377 396 377 396 <xref ref-type="bibr" rid="b7">Bronson <italic>et al</italic>, 2003</xref>
###xml 403 408 403 408 <italic>Vac14</italic>
###xml 408 412 408 409 <italic>&#946;</italic>
###xml 413 416 410 413 <italic>geo</italic>
###xml 408 416 408 413 <sup><italic>&#946;</italic>&#8722;<italic>geo</italic></sup>
###xml 521 526 518 523 <italic>et al</italic>
###xml 515 532 512 529 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 600 605 597 602 <italic>Vac14</italic>
###xml 605 609 602 603 <italic>&#946;</italic>
###xml 610 613 604 607 <italic>geo</italic>
###xml 605 613 602 607 <sup><italic>&#946;</italic>&#8722;<italic>geo</italic></sup>
###xml 177 181 <span type="species:ncbi:10090">Mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
The ingls mutation arose at The Jackson Laboratory in 1991 on the inbred strain DBA/2J and is maintained as a congenic line on the C57BL/6J background (current generation F23). Mice are available from the Jackson laboratory as B6.D2-ingls/J (stock 003095). Preliminary description of the mutant and its location on chromosome 8 was submitted to the Jackson Laboratory website (Bronson et al, 2003). The Vac14beta-geo line was generated from a gene-trap ES cell from strain 129/Ola, and it lacks detectable protein (Zhang et al, 2007). The gene-trap mice were first crossed to strain C57BL/6J and the Vac14beta-geo mutant has been maintained as a mixed stock (C57BL/6J X 129/Ola)F12, by mating heterozygotes.
###end p 77
###begin title 78
Genotyping
###end title 78
###begin p 79
###xml 177 182 177 182 <italic>Vac14</italic>
###xml 205 210 205 210 <italic>ingls</italic>
###xml 465 468 465 468 <italic>Sac</italic>
###xml 497 506 497 506 <xref ref-type="fig" rid="f1">Figure 1B</xref>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 113 118 <span type="species:ncbi:10090">Mouse</span>
###xml 171 176 <span type="species:ncbi:10090">Mouse</span>
SNP1, CTC AAA CTT CAC CCC (C/T) AGC CCC ACC CCA ACC, is located at nucleotide 111,611,180 of mouse chromosome 8 (Mouse Build 37.1, ) and was genotyped at Kbiosciences (). Mouse Vac14 exon 4 containing the ingls mutation is amplified with the following primer pair, designated as Vac14E4: forward, 5'CAG CCA GTG GGA ACA ACC GTG TGA; and reverse, 5' ACA TAG ACA TGC AAG CAG GCA AAG. These primers are used for genotyping the L156R mutation by virtue of the loss of a SacI site in the mutant allele (Figure 1B).
###end p 79
###begin title 80
Histology
###end title 80
###begin p 81
###xml 196 201 196 201 <italic>et al</italic>
###xml 192 207 192 207 <xref ref-type="bibr" rid="b23">Liu <italic>et al</italic>, 2007</xref>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 283 289 <span type="species:ncbi:9986">rabbit</span>
Tissues were sectioned and stained with H&E at HistoServ (Germantown, MD). For GFAP staining, mice were perfused with 4% paraformaldehyde, and tissues were sectioned and stained as described (Liu et al, 2007). Twenty-micrometer cryostat sections were stained with anti-GFAP (1:1000, rabbit polyclonal, Sigma) and with secondary antibodies conjugated with biotin (1:200, Vector Laboratory, Burlingame, CA) followed by avidin-biotin complex (1:50, Elite, Vector Laboratory). Immunoreactivity was visualized with diaminobenzidine and 0.02% hydrogen peroxide for up to 5 min.
###end p 81
###begin title 82
Western blot
###end title 82
###begin p 83
###xml 317 322 317 322 <italic>et al</italic>
###xml 311 328 311 328 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 407 412 407 412 <italic>et al</italic>
###xml 402 419 402 419 <xref ref-type="bibr" rid="b15">Duex <italic>et al</italic>, 2006b</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 183 186 <span type="species:ncbi:9685">Cat</span>
###xml 271 274 <span type="species:ncbi:9685">cat</span>
###xml 335 340 <span type="species:ncbi:4932">yeast</span>
For mouse samples, dissected brain cortex was homogenized in 150 mM NaCl, 1.0% NP-40, 0.5% deoxycholate, 0.1% SDS, 1 mM EDTA, 50 mM Tris-HCl, pH 8.0, with protease inhibitors; Roche (Cat. no. 11 873 580 001), and lysed on ice for 1 h. Molecular weight markers; Amersham (cat. no. RPN7567). Anti-Vac14 antibody (Zhang et al, 2007). For yeast samples, experiments were performed as described previously (Duex et al, 2006b).
###end p 83
###begin title 84
###xml 53 58 <span type="species:ncbi:4932">yeast</span>
Phosphoinositides and vacuoles in cultured cells and yeast cells
###end title 84
###begin p 85
###xml 105 106 105 106 <sup>3</sup>
###xml 217 222 217 222 <italic>et al</italic>
###xml 211 228 211 228 <xref ref-type="bibr" rid="b33">Zhang <italic>et al</italic>, 2007</xref>
###xml 473 478 473 478 <italic>et al</italic>
###xml 468 485 468 485 <xref ref-type="bibr" rid="b15">Duex <italic>et al</italic>, 2006b</xref>
###xml 403 408 <span type="species:ncbi:4932">yeast</span>
For cultured cells, primary fibroblasts were starved in inositol-free DMEM 12 h and labelled with myo-[2-3H]inositol, 36 h. Lipids were extracted, deacylated, and analysed by anion-exchange HPLC chromatography (Zhang et al, 2007). Images of cells were taken on an Axioscope 2 (Carl Zeiss MicroImaging, Jena, Germany) using a LUCPlanFL N x 40/0.60 Ph2 objective with a DeltaVision microscope system. For yeast cells, experiments were performed as described previously (Duex et al, 2006b).
###end p 85
###begin title 86
Prediction of HEAT repeat motifs
###end title 86
###begin p 87
###xml 46 59 46 59 <italic>S. cerevisiae</italic>
###xml 75 90 75 90 <italic>Ashbya gossypii</italic>
###xml 115 136 115 136 <italic>Aspergillus fumigatus</italic>
###xml 158 178 158 178 <italic>Kluyveromyces lactis</italic>
###xml 194 213 194 213 <italic>Yarrowia lipolytica</italic>
###xml 229 244 229 244 <italic>Gibberella zeae</italic>
###xml 265 281 265 281 <italic>Candida glabrata</italic>
###xml 297 312 297 312 <italic>Ustilago maydis</italic>
###xml 331 347 331 347 <italic>Candida albicans</italic>
###xml 370 387 370 387 <italic>Neurospora crassa</italic>
###xml 409 430 409 430 <italic>Debaryomyces hansenii</italic>
###xml 453 461 453 461 <italic>S. pombe</italic>
###xml 483 511 483 511 <italic>Cryptococcus var. neoformans</italic>
###xml 535 547 535 547 <italic>Homo sapiens</italic>
###xml 563 585 563 585 <italic>Caenorhabditis elegans</italic>
###xml 599 614 599 614 <italic>D. melanogaster</italic>
###xml 628 648 628 648 <italic>Arabidopsis thaliana</italic>
###xml 779 792 779 792 <italic>S. cerevisiae</italic>
###xml 1104 1117 1104 1117 <italic>S. cerevisiae</italic>
###xml 46 59 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 75 101 <span type="species:ncbi:284811">Ashbya gossypii ATCC 10895</span>
###xml 115 142 <span type="species:ncbi:330879">Aspergillus fumigatus Af293</span>
###xml 158 178 <span type="species:ncbi:28985">Kluyveromyces lactis</span>
###xml 194 213 <span type="species:ncbi:4952">Yarrowia lipolytica</span>
###xml 229 249 <span type="species:ncbi:229533">Gibberella zeae PH-1</span>
###xml 265 281 <span type="species:ncbi:5478">Candida glabrata</span>
###xml 297 316 <span type="species:ncbi:237631">Ustilago maydis 521</span>
###xml 331 354 <span type="species:ncbi:237561">Candida albicans SC5314</span>
###xml 370 393 <span type="species:ncbi:367110">Neurospora crassa OR74A</span>
###xml 409 430 <span type="species:ncbi:4959">Debaryomyces hansenii</span>
###xml 453 461 <span type="species:ncbi:4896">S. pombe</span>
###xml 483 495 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 535 547 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 563 585 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 599 614 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 628 648 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 779 792 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1104 1117 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1122 1127 <span type="species:ncbi:9606">human</span>
###xml 1173 1178 <span type="species:ncbi:9606">human</span>
Seventeen Vac14 sequences analysed were from: S. cerevisiae (NP_013490.1); Ashbya gossypii ATCC 10895 (NP_984909); Aspergillus fumigatus Af293 (XP_751167.1); Kluyveromyces lactis (XP_454179.1); Yarrowia lipolytica (XP_501232.1); Gibberella zeae PH-1 (XP_390022.1); Candida glabrata (XP_447078.1); Ustilago maydis 521(XP_757421.1); Candida albicans SC5314 (XP_716167.1); Neurospora crassa OR74A (XP_959537.1); Debaryomyces hansenii CBS767 (XP_456837.1); S. pombe 972 h (NP_596363.1); Cryptococcus var. neoformans B-3501A (XP_775858.1); Homo sapiens (NP_060522.3); Caenorhabditis elegans (NP_492215); D. melanogaster (NP_650208); Arabidopsis thaliana (NP_565275). Potential HEAT repeats in each sequence are identified using REP without an applied confidence threshold. Regions of S. cerevisiae Vac14 with homology to the predicted HEAT repeat in other species were assumed to form HEAT repeats. The resulting repeats were further analysed by the secondary structure prediction program (). Regions predicted to form two helices connected with a loop were selected. This predicted 21 and 17 HEAT repeats in S. cerevisiae and human Vac14, respectively. We manually aligned the human Vac14 sequence with random seed sequences from the Pfam database and obtained the same 17 repeats.
###end p 87
###begin title 88
Fluorescence microscopy
###end title 88
###begin p 89
###xml 39 44 39 44 <italic>et al</italic>
###xml 34 51 34 51 <xref ref-type="bibr" rid="b14">Duex <italic>et al</italic>, 2006a</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast cells labelled with FM4-64 (Duex et al, 2006a). Fluorescence and differential interference contrast (DIC) images generated with a Deltavision system (Applied Precision, WA). Images are processed using Adobe Photoshop.
###end p 89
###begin title 90
###xml 23 28 <span type="species:ncbi:4932">yeast</span>
Immunoprecipitation in yeast cells
###end title 90
###begin p 91
###xml 235 236 235 236 <italic>g</italic>
###xml 471 472 465 466 <italic>g</italic>
A total of 10 OD log-phase cells were lysed in lysis buffer; 50 mM Tris pH 7.5, 120 mM NaCl, 10 mM EDTA, 1 mM EGTA, 5 mM 2-glycerophosphate, 1 mM PMSF, 10 mM benzamidine, 1 mg/ml leupeptin, 5 mg/ml aprotonin. Extracts were spun at 500 g to sediment unbroken cells. Octyl-glucoside (Sigma) was added to the supernatant to a final concentration of 0.5%. Subsequent manipulations were performed at 4 degreesC. Resulting extracts were incubated for 30 min and spun at 13 000 g, 10 min. Anti-HA (COVANCE), anti-GFP (Roche Applied Science) or anti-V5 (Invitrogen) were added to the supernatant and incubated for 1 h. Protein A immobilized on Sepharose beads (Sigma) was added and incubated for 1 h. Protein complexes bound to the beads were washed seven times with lysis buffer containing 0.5% octyl-glucoside, then eluted in sample buffer (50 mM Tris, pH6.8, 2% SDS, 5% beta-mercaptoethanol, 10% glycerol, 0.01% BPB) at 80degreesC, 5 min. SDS-PAGE and western blot analysis were used to detect Vac14-HA or V5, Vac7, Fab1, Fig4-Myc.
###end p 91
###begin title 92
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid analysis
###end title 92
###begin p 93
###xml 0 5 0 5 <italic>VAC14</italic>
###xml 29 32 29 32 <italic>Xma</italic>
###xml 34 37 34 37 <italic>Sal</italic>
###xml 61 65 61 65 <italic>FAB1</italic>
###xml 119 122 119 122 <italic>Eco</italic>
###xml 125 128 125 128 <italic>Bgl</italic>
###xml 145 149 145 149 <italic>VAC7</italic>
###xml 198 201 198 201 <italic>Sma</italic>
###xml 203 206 203 206 <italic>Sal</italic>
###xml 222 227 222 227 <italic>ATG18</italic>
###xml 251 254 251 254 <italic>Eco</italic>
###xml 257 260 257 260 <italic>Sal</italic>
###xml 276 280 276 280 <italic>FIG4</italic>
###xml 304 307 304 307 <italic>Bam</italic>
###xml 310 313 310 313 <italic>Pst</italic>
###xml 630 635 624 629 <italic>et al</italic>
###xml 624 641 618 635 <xref ref-type="bibr" rid="b22">James <italic>et al</italic>, 1996</xref>
###xml 366 371 <span type="species:ncbi:4932">yeast</span>
###xml 552 557 <span type="species:ncbi:4932">yeast</span>
VAC14 was subcloned into the XmaI-SalI site of pGAD or pGBD. FAB1 encoding amino acids 538-1085 was subcloned into the EcoRI-BglII site of pGBD. VAC7 encoding amino acids 394-918 was subcloned into SmaI-SalI site of pGBD. ATG18 was subcloned into the EcoRI-SalI site of pGBD. FIG4 was subcloned into the BamHI-PstI site of pGBD. Plasmids were cotransformed into the yeast strain PJ69-4A, transformants were plated onto SC-LEU-TRP, replica-plated onto SC-LEU-TRP, SC-LEU-TRP-ADE-HIS+3AT, or SC-LEU-TRP-ADE-HIS and grown for 4-10 days at 24degreesC. The yeast strain PJ69-4A and the pGAD and pGBD vectors have been described (James et al, 1996).
###end p 93
###begin title 94
Glycerol gradients
###end title 94
###begin p 95
A total of 12 ml of 10-50% glycerol gradients were prepared in the lysis buffer with 0.5% octyl-glucoside. S13 lysates were prepared from 20 OD cells as described above, loaded on the top and spun at 31 000 r.p.m. for 18 h at 4degreesC. Fractions (1 ml) were precipitated with TCA, and 1/10 of the sample was separated by SDS-PAGE.
###end p 95
###begin title 96
Supplementary Material
###end title 96
###begin p 97
Supplementary video
###end p 97
###begin p 98
Supplementary Information
###end p 98
###begin p 99
###xml 392 397 <span type="species:ncbi:10090">Mouse</span>
We thank Dr Lucia Rameh for the protocol to generate the labelled lipid standards. We thank Drs Yui Jin, Rob Piper, Guy Lenk, Cole Ferguson, and members of the Weisman and Meisler labs for helpful discussions. We thank Emily Kauffman for technical assistance. This work was supported by NIH grants R01-GM50403 to LSW, R01-GM24872 to MHM, T32 GM07544 training grant to CYC, and RRO1183 to the Mouse Mutant Resource at the Jackson Laboratory.
###end p 99
###begin article-title 100
Homology-based method for identification of protein repeats using statistical significance estimates. 
###end article-title 100
###begin article-title 101
Organelle identity and the signposts for membrane traffic. 
###end article-title 101
###begin article-title 102
Myotubularin-related (MTMR) phospholipid phosphatase proteins in the peripheral nervous system. 
###end article-title 102
###begin article-title 103
Vac7p, a novel vacuolar protein, is required for normal vacuole inheritance and morphology. 
###end article-title 103
###begin article-title 104
Osmotic stress-induced increase of phosphatidylinositol 3,5-bisphosphate requires Vac14p, an activator of the lipid kinase Fab1p. 
###end article-title 104
###begin article-title 105
Assembly of a Fab1 phosphoinositide kinase signaling complex requires the Fig4 phosphoinositide phosphatase. 
###end article-title 105
###begin article-title 106
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Infantile gliosis (ingls) a new spontaneous mutation in the mouse. MGI Direct Data Submission 
###end article-title 106
###begin article-title 107
Structure of the nuclear transport complex karyopherin-[beta]2-Ran[dot]GppNHp. 
###end article-title 107
###begin article-title 108
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. 
###end article-title 108
###begin article-title 109
Structure of importin-[beta] bound to the IBB domain of importin-[alpha]. 
###end article-title 109
###begin article-title 110
Phosphoinositides in cell regulation and membrane dynamics. 
###end article-title 110
###begin article-title 111
Vac14 controls PtdIns(3,5)P(2) synthesis and Fab1-dependent protein trafficking to the multivesicular body. 
###end article-title 111
###begin article-title 112
Svp1p defines a family of phosphatidylinositol 3,5-bisphosphate effectors. 
###end article-title 112
###begin article-title 113
Phosphoinositide 5-phosphatase Fig 4p is required for both acute rise and subsequent fall in stress-induced phosphatidylinositol 3,5-bisphosphate levels. 
###end article-title 113
###begin article-title 114
The Vac14p-Fig4p complex acts independently of Vac7p and couples PI3,5P2 synthesis and turnover. 
###end article-title 114
###begin article-title 115
Atg18 regulates organelle morphology and Fab1 kinase activity independent of its membrane recruitment by phosphatidylinositol 3,5-bisphosphate. 
###end article-title 115
###begin article-title 116
Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1. 
###end article-title 116
###begin article-title 117
Regulation of Fab1 phosphatidylinositol 3-phosphate 5-kinase pathway by Vac7 protein and Fig4, a polyphosphoinositide phosphatase family member. 
###end article-title 117
###begin article-title 118
Fab1p is essential for PtdIns(3)P 5-kinase activity and the maintenance of vacuolar size and membrane homeostasis. 
###end article-title 118
###begin article-title 119
The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. 
###end article-title 119
###begin article-title 120
Localized PtdIns 3,5-P2 synthesis to regulate early endosome dynamics and fusion. 
###end article-title 120
###begin article-title 121
###xml 90 95 <span type="species:ncbi:4932">yeast</span>
Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. 
###end article-title 121
###begin article-title 122
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
A transgenic mouse class-III beta tubulin reporter using yellow fluorescent protein. 
###end article-title 122
###begin article-title 123
PI-loting membrane traffic. 
###end article-title 123
###begin article-title 124
The ATRs, ATMs, and TORs are giant HEAT repeat proteins. 
###end article-title 124
###begin article-title 125
Vacuole size control: regulation of PtdIns(3,5)P2 levels by the vacuole-associated Vac14-Fig4 complex, a PtdIns(3,5)P2-specific phosphatase. 
###end article-title 125
###begin article-title 126
The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport. 
###end article-title 126
###begin article-title 127
Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. 
###end article-title 127
###begin article-title 128
Phosphoinositides' link to neurodegeneration. 
###end article-title 128
###begin article-title 129
Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. 
###end article-title 129
###begin article-title 130
###xml 96 101 <span type="species:ncbi:4932">yeast</span>
Novel PI(4)P 5-kinase homologue, Fab1p, essential for normal vacuole function and morphology in yeast. 
###end article-title 130
###begin article-title 131
Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. 
###end article-title 131
###begin article-title 132
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. 
###end article-title 132
###begin p 133
###xml 0 5 0 5 <italic>ingls</italic>
###xml 41 52 41 52 <italic>Vac14&#8211;L156R</italic>
###xml 55 56 55 56 <bold>A</bold>
###xml 58 63 58 63 <italic>ingls</italic>
###xml 159 170 159 170 <italic>ingls/Vac14</italic>
###xml 170 171 170 171 <sup>&#8722;</sup>
###xml 230 231 230 231 <bold>B</bold>
###xml 281 286 281 286 <italic>ingls</italic>
###xml 308 319 308 319 <italic>ingls/Vac14</italic>
###xml 319 320 319 320 <sup>&#8722;</sup>
###xml 367 368 367 368 <bold>C</bold>
###xml 406 412 406 412 <italic>ingls-</italic>
###xml 417 422 417 422 <italic>Vac14</italic>
###xml 435 436 435 436 <bold>D</bold>
###xml 478 483 478 483 <italic>ingls</italic>
###xml 551 552 551 552 <bold>E</bold>
###xml 558 563 558 563 <italic>ingls</italic>
###xml 722 723 722 723 <bold>F</bold>
###xml 790 795 790 795 <italic>ingls</italic>
###xml 827 828 827 828 <bold>G</bold>
###xml 856 857 856 857 <sub>2</sub>
###xml 887 892 887 892 <italic>ingls</italic>
###xml 900 901 900 901 <bold>H</bold>
###xml 903 904 903 904 <bold>I</bold>
###xml 953 958 953 958 <italic>Vac14</italic>
###xml 990 995 990 995 <italic>ingls</italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 651 656 <span type="species:ncbi:4932">yeast</span>
###xml 708 713 <span type="species:ncbi:9606">human</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
###xml 947 952 <span type="species:ncbi:9606">human</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
ingls is caused by the missense mutation Vac14-L156R. (A) ingls homozygous mice at postnatal day 14 (P14) display reduced body weight and diluted coat colour. ingls/Vac14- compound heterozygotes at P14 are similar in appearance. (B) Severe hydrocephalus and enlarged ventricles in ingls homozygote (P16) and ingls/Vac14- compound heterozygotes (P14) (H&E staining). (C) GFAP-stained astrocytes in neonatal ingls- and Vac14-null mice. (D) Sequence chromatogram from exon 4 of an ingls/+ heterozygote demonstrates the c467 T>G nucleotide substitution. (E) The ingls mutation changes leucine 156 to arginine. Leucine 156 is evolutionarily invariant from yeast to mammals. Dots indicate amino-acid identity with human Vac14. (F) Western blot of Vac14 protein in brain extracts of wild-type and ingls mice. Loading control, GAPDH. (G) Reduced levels of PI(3,5)P2 in cultured fibroblasts from ingls mice. (H, I) Rescue of vacuole formation by wild-type human Vac14 cDNA. Primary fibroblasts from ingls mice transfected with the indicated plasmids. At 24 h, cells were fixed with 4% paraformaldehyde in PBS for 10 min, room temperature. (H). Fluorescent cells were scored for the presence of vacuoles. Mean+/-s.d. for three independent experiments, >100 cells per experiment. (I) Representative cells are shown; arrows mark transfected cells. Bar, 20 mum.
###end p 133
###begin p 134
###xml 35 36 35 36 <bold>A</bold>
###xml 79 92 79 92 <italic>S. cerevisiae</italic>
###xml 197 210 197 210 <italic>S. cerevisiae</italic>
###xml 270 275 270 275 <italic>ingls</italic>
###xml 280 287 280 287 <italic>vac14-2</italic>
###xml 399 400 399 400 <italic>P</italic>
###xml 400 405 400 401 <sub>&#952;</sub>
###xml 413 414 409 410 <bold>B</bold>
###xml 962 963 952 953 <bold>C</bold>
###xml 1269 1270 1253 1254 <bold>D</bold>
###xml 1333 1334 1317 1318 <bold>E</bold>
###xml 1384 1395 1368 1379 <italic>VAC14&#8211;Venus</italic>
###xml 1414 1415 1398 1399 <bold>F</bold>
###xml 1678 1688 1662 1668 <italic>vac14&#916;</italic>
###xml 1689 1698 1669 1674 <italic>fig4&#916;</italic>
###xml 1699 1710 1675 1686 <italic>ATG18&#8211;Venus</italic>
###xml 1735 1743 1711 1719 <italic>VAC14&#8211;V5</italic>
###xml 1755 1763 1731 1739 <italic>FIG4&#8211;Myc</italic>
###xml 79 92 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 197 210 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 416 421 <span type="species:ncbi:4932">Yeast</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
###xml 589 594 <span type="species:ncbi:9606">human</span>
###xml 699 704 <span type="species:ncbi:4932">yeast</span>
###xml 965 970 <span type="species:ncbi:4932">Yeast</span>
###xml 1009 1014 <span type="species:ncbi:4932">yeast</span>
###xml 1542 1548 <span type="species:ncbi:9913">bovine</span>
Vac14 nucleates the Fab1 complex. (A) Vac14 contains 21 and 17 HEAT repeats in S. cerevisiae (top) and mammalian Vac14 (bottom), respectively. Identical colours indicate homologous repeats between S. cerevisiae and mammalian Vac14. Red asterisk and blue arrows indicate ingls and vac14-2 mutations, respectively. Underlines: HEAT repeats identified by REP with a confidence threshold better than at Ptheta<1e-6. (B) Yeast two-hybrid test of human Vac14 (HsVac14) or human Vac14-L156R (HsVac14-L>R), fused with the GAL4-activation domain (AD), interaction with itself, residues 346-1134 of human Fab1 or full-length Fig4, fused with the GAL4-binding domain (BD). Plasmids were cotransformed into the yeast cells and transformants were plated onto the SC-LEU-TRP plate and replica-plated onto SC-LEU-TRP (control) or SC-LEU-TRP-ADE-HIS plate (test). Plates were incubated at 24degreesC for 10 days. Growth on the test plate indicates protein-protein interaction. (C) Yeast two-hybrid test of Gal4-AD fused with yeast Vac14p tested with Gal4-BD fused with either Fab1p, Fig4p, Vac7p, Atg18p or Vac14p. Transformants were plated onto SC-LEU-TRP and replica-plated onto SC-LEU-TRP (control) or SC-LEU-TRP-ADE-HIS+3AT (test). Plates were incubated at 24degreesC for 7 days. (D) Schematic of interactions between Fab1 and Fab1 regulators. (E) Vac14p-Venus coprecipitated Vac7p. Wild-type or VAC14-Venus cells were used. (F) Analysis on glycerol gradients (10-50%) indicate that Fab1p and regulators form a complex >670 kDa. Molecular weight markers bovine serum albumin, 66 kDa, and thyroglobulin, 670 kDa, run in an adjacent tube. Representative profile of two independent gradients. vac14Delta/fig4Delta/ATG18-Venus cells expressing pRS413-VAC14-V5 and pRS415-FIG4-Myc were used.
###end p 134
###begin p 135
###xml 183 184 183 184 <bold>A</bold>
###xml 209 219 209 219 <italic>FAB1&#8211;3xGFP</italic>
###xml 221 231 221 231 <italic>FIG4&#8211;3xGFP</italic>
###xml 236 247 236 247 <italic>VAC14&#8211;Venus</italic>
###xml 293 294 293 294 <bold>B</bold>
###xml 296 306 296 306 <italic>FAB1&#8211;3xGFP</italic>
###xml 310 320 310 320 <italic>FIG4&#8211;3xGFP</italic>
###xml 321 331 321 327 <italic>vac14&#916;</italic>
###xml 339 349 335 345 <italic>FAB1&#8211;3xGFP</italic>
###xml 353 364 349 360 <italic>VAC14&#8211;Venus</italic>
###xml 365 374 361 366 <italic>fig4&#916;</italic>
###xml 385 395 377 387 <italic>FIG4&#8211;3xGFP</italic>
###xml 399 410 391 402 <italic>VAC14&#8211;Venus</italic>
###xml 411 420 403 408 <italic>fab1&#916;</italic>
The localization of Fab1p, Fig4p, and Vac14p to the vacuole membrane requires the presence of all three proteins. Cells labelled with FM4-64 (red) to visualize the vacuole membrane. (A) Wild-type strains with FAB1-3xGFP, FIG4-3xGFP, or VAC14-Venus integrated at the proper chromosomal locus. (B) FAB1-3xGFP or FIG4-3xGFP/vac14Delta cells, FAB1-3xGFP or VAC14-Venus/fig4Delta cells and FIG4-3xGFP or VAC14-Venus/fab1Delta cells.
###end p 135
###begin p 136
###xml 68 69 68 69 <bold>A</bold>
###xml 88 99 88 99 <italic>vac14&#8211;L149R</italic>
###xml 138 139 138 139 <bold>B</bold>
###xml 192 202 192 198 <italic>vac14&#916;</italic>
###xml 228 236 224 232 <italic>VAC14-HA</italic>
###xml 247 261 243 257 <italic>vac14&#8211;L149R&#8211;HA</italic>
###xml 357 358 353 354 <bold>C</bold>
###xml 360 371 356 367 <italic>vac14&#8211;L149R</italic>
###xml 421 432 417 428 <italic>vac14&#8211;L149R</italic>
###xml 473 483 469 475 <italic>vac14&#916;</italic>
###xml 547 557 539 545 <italic>vac14&#916;</italic>
###xml 589 594 577 582 <italic>VAC14</italic>
###xml 603 614 591 602 <italic>vac14&#8211;L149R</italic>
###xml 616 623 604 611 <italic>vac14-L</italic>
###xml 624 625 612 613 <italic>R</italic>
###xml 649 650 637 638 <bold>D</bold>
###xml 794 801 782 789 <italic>vac14-L</italic>
###xml 802 803 790 791 <italic>R</italic>
###xml 1025 1026 1013 1014 <bold>E</bold>
###xml 1144 1154 1132 1138 <italic>vac14&#916;</italic>
###xml 1158 1177 1142 1157 <italic>vac14&#916;/FAB1&#8211;TAP</italic>
###xml 1203 1211 1183 1191 <italic>VAC14&#8211;HA</italic>
###xml 1228 1242 1208 1222 <italic>vac14&#8211;L149R&#8211;HA</italic>
###xml 1244 1245 1224 1225 <italic>L</italic>
###xml 1246 1247 1226 1227 <italic>R</italic>
###xml 1306 1307 1286 1287 <bold>F</bold>
###xml 1371 1381 1351 1357 <italic>vac14&#916;</italic>
###xml 1382 1392 1358 1368 <italic>FAB1&#8211;3XGFP</italic>
###xml 1424 1429 1400 1405 <italic>VAC14</italic>
###xml 1440 1451 1416 1427 <italic>vac14&#8211;L149R</italic>
###xml 1453 1460 1429 1436 <italic>vac14-L</italic>
###xml 1461 1462 1437 1438 <italic>R</italic>
###xml 1501 1502 1477 1478 <bold>G</bold>
###xml 1508 1519 1484 1495 <italic>vac14&#8211;L149R</italic>
###xml 1567 1568 1543 1544 <sub>2</sub>
###xml 1605 1615 1581 1587 <italic>vac14&#916;</italic>
###xml 1640 1645 1612 1617 <italic>VAC14</italic>
###xml 1656 1667 1628 1639 <italic>vac14&#8211;L149R</italic>
###xml 1688 1689 1660 1661 <sup>3</sup>
###xml 1802 1803 1774 1775 <sup>3</sup>
###xml 1827 1828 1799 1800 <italic>n</italic>
###xml 652 657 <span type="species:ncbi:4932">Yeast</span>
The vac14-L149R mutant is defective in its association with Fab1p. (A) Schematic of the vac14-L149R mutant. Red asterisk: mutation site. (B) vac14-L149R protein is stable. Cell lysates from a vac14Delta strain expressing pRS413-VAC14-HA or pRS413-vac14-L149R-HA (L>R) analysed by western blot. Vac14p detected with anti-HA antibody. Loading control: Pgk1. (C) vac14-L149R mutant retains partial function. Vacuoles in the vac14-L149R mutant are intermediate in size between vac14Delta and wild-type vacuoles. Vacuoles visualized with FM4-64 (red). vac14Delta strain transformed with pRS413-VAC14, pRS413-vac14-L149R (vac14-L>R), or pRS413 (vector). (D) Yeast two-hybrid test of Vac14p or vac14p-L149R interaction with itself, Fab1p, Fig4p, Vac7p, and Atg18p. Full-length Vac14p or vac14p-L149R (vac14-L>R) fused with Gal4-AD and Gal4-BD. Full-length Fig4p; Atg18p; amino acids 394-918 of Vac7p, amino acids 538-1085 of Fab1p, fused with Gal4-BD. Upper panel, SC-LEU-TRP (control); lower panel, SD-LEU-TRP-ADE-HIS+3AT (test). (E) Pull-down of Fab1p-TAP coprecipitates wild-type Vac14p, but not vac14p-L149R. Detergent-solubilized extracts from a vac14Delta or vac14Delta/FAB1-TAP strain expressing pRS413-VAC14-HA (WT), or pRS413-vac14-L149R-HA (L>R). Vac14p but not vac14p-L149R binds Fab1p-TAP IgG beads. (F) Fab1p localization is defective in the vac14p-L149R mutant. A vac14Delta/FAB1-3XGFP strain transformed with pRS413-VAC14 or pRS413-vac14-L149R (vac14-L>R). FM4-64 (red), Fab1p-3xGFP (green). (G) The vac14-L149R mutant does not increase its levels of PI(3,5)P2 in response to hyperosmotic stress. vac14Delta cells expressing pRS413-VAC14 or pRS413-vac14-L149R were labelled with [3H]inositol for 16 h and exposed to 0.9 M NaCl for times indicated. Values are the percentage of total extracted [3H]PI. Error bars: s.d. (n=3).
###end p 136
###begin p 137
###xml 97 104 97 104 <italic>in vivo</italic>
###xml 107 108 107 108 <bold>A</bold>
###xml 127 133 127 133 <italic>fab1-2</italic>
###xml 180 181 180 181 <bold>B</bold>
###xml 282 291 282 287 <italic>fab1&#916;</italic>
###xml 316 320 312 316 <italic>FAB1</italic>
###xml 331 337 327 333 <italic>fab1-2</italic>
###xml 362 363 358 359 <bold>C</bold>
###xml 365 370 361 366 <italic>VAC14</italic>
###xml 386 390 382 386 <italic>FAB1</italic>
###xml 400 406 396 402 <italic>fab1-2</italic>
###xml 433 437 429 433 <italic>FAB1</italic>
###xml 441 447 437 443 <italic>fab1-2</italic>
###xml 465 470 461 466 <italic>VAC14</italic>
###xml 484 489 480 485 <italic>VAC14</italic>
###xml 510 514 506 510 <italic>FAB1</italic>
###xml 518 524 514 520 <italic>fab1-2</italic>
###xml 692 693 682 683 <bold>D</bold>
###xml 694 695 684 685 <bold>E</bold>
###xml 806 810 796 800 <italic>FAB1</italic>
###xml 821 827 811 817 <italic>fab1-2</italic>
###xml 843 852 833 838 <italic>fab1&#916;</italic>
###xml 853 864 839 850 <italic>VAC14&#8211;Venus</italic>
###xml 927 931 913 917 <italic>FAB1</italic>
###xml 942 948 928 934 <italic>fab1-2</italic>
###xml 964 973 950 955 <italic>fab1&#916;</italic>
###xml 974 984 956 966 <italic>FIG4&#8211;3xGFP</italic>
###xml 994 995 976 977 <bold>F</bold>
###xml 1027 1033 1009 1015 <italic>fab1-2</italic>
###xml 1089 1099 1071 1081 <italic>FAB1&#8211;3xGFP</italic>
###xml 1110 1122 1092 1104 <italic>fab1-2&#8211;3xGFP</italic>
###xml 1136 1145 1118 1123 <italic>fab1&#916;</italic>
###xml 1150 1159 1128 1133 <italic>fab1&#916;</italic>
###xml 1160 1171 1134 1145 <italic>VAC14&#8211;Venus</italic>
###xml 1175 1184 1149 1154 <italic>fab1&#916;</italic>
###xml 1185 1195 1155 1165 <italic>FIG4&#8211;3xGFP</italic>
###xml 1232 1233 1202 1203 <bold>G</bold>
###xml 1239 1245 1209 1215 <italic>fab1-2</italic>
###xml 1305 1306 1275 1276 <sub>2</sub>
###xml 1343 1352 1313 1318 <italic>fab1&#916;</italic>
###xml 1377 1381 1343 1347 <italic>FAB1</italic>
###xml 1392 1398 1358 1364 <italic>fab1-2</italic>
###xml 1424 1432 1390 1398 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 1452 1453 1418 1419 <italic>n</italic>
###xml 408 413 <span type="species:ncbi:4932">Yeast</span>
Formation of a ternary complex of Fab1p, Vac14p, and Fig4p is required for Fab1p kinase activity in vivo. (A) Schematic of the fab1-2 allele; purple asterisk, the G864E mutation. (B) Fab1-2 protein is present at wild-type levels. Cell lysates analysed by western blot analysis from fab1Delta cells expressing pRS416-FAB1 or pRS416-fab1-2. Equal protein loaded. (C) VAC14 interacts with FAB1, but not fab1-2. Yeast two-hybrid test of FAB1 or fab1-2 interaction with VAC14. Full-length VAC14 fused with Gal4-AD. FAB1 or fab1-2, amino acids 538-1085. fused with Gal4-BD. Upper panel, SC-LEU -TRP (control); lower panel, SC-LEU-TRP-ADE-HIS+3AT (test). Plates incubated at 24degreesC for 4 days. (D-E) fab1-2 does not form a complex with Vac14p and Fig4p. (D) Vac14p-Venus does not coprecipitate fab1-2. pRS416-FAB1 or pRS416-fab1-2 expressed in a fab1Delta/VAC14-Venus strain. (E) fig4p-3xGFP does not coprecipitate fab1-2. pRS416-FAB1 or pRS416-fab1-2 expressed in a fab1Delta/FIG4-3xGFP strain. (F) fab1-2, Vac14p and Fig4p in a fab1-2 mutant do not localize to the vacuole membrane. pRS416-FAB1-3xGFP or pRS416-fab1-2-3xGFP expressed in fab1Delta, or fab1Delta/VAC14-Venus or fab1Delta/FIG4-3xGFP. Cells labelled with FM4-64 (red). (G) The fab1-2 mutant does not transiently increase its levels of PI(3,5)P2 in response to hyperosmotic stress. fab1Delta cells expressing pRS416-FAB1 or pRS416-fab1-2 measured as described in Figure 4. Error bars: s.d. (n=3).
###end p 137
###begin p 138
###xml 43 44 43 44 <bold>A</bold>
###xml 46 53 46 53 <italic>vac14-2</italic>
###xml 137 138 137 138 <sub>2</sub>
###xml 140 150 140 146 <italic>vac14&#916;</italic>
###xml 175 180 171 176 <italic>VAC14</italic>
###xml 191 198 187 194 <italic>vac14-2</italic>
###xml 222 223 218 219 <bold>B</bold>
###xml 225 232 221 228 <italic>vac14-2</italic>
###xml 268 269 264 265 <sub>2</sub>
###xml 312 313 308 309 <sub>2</sub>
###xml 345 346 341 342 <sub>2</sub>
###xml 357 367 353 359 <italic>vac14&#916;</italic>
###xml 392 397 384 389 <italic>VAC14</italic>
###xml 408 415 400 407 <italic>vac14-2</italic>
###xml 441 449 433 441 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 469 470 461 462 <italic>n</italic>
###xml 476 477 468 469 <bold>C</bold>
###xml 579 589 571 577 <italic>vac14&#916;</italic>
###xml 614 622 602 610 <italic>VAC14&#8211;HA</italic>
###xml 638 654 626 642 <italic>vac14-2&#8211;HA(14-2)</italic>
###xml 681 682 669 670 <bold>D</bold>
###xml 759 764 747 752 <italic>VAC14</italic>
###xml 768 775 756 763 <italic>vac14-2</italic>
###xml 814 818 802 806 <italic>FAB1</italic>
###xml 820 824 808 812 <italic>FIG4</italic>
###xml 826 830 814 818 <italic>VAC7</italic>
###xml 832 837 820 825 <italic>ATG18</italic>
###xml 980 981 962 963 <bold>E</bold>
###xml 1051 1061 1033 1039 <italic>vac14&#916;</italic>
###xml 1065 1084 1043 1058 <italic>vac14&#916;/FAB1&#8211;TAP</italic>
###xml 1110 1118 1084 1092 <italic>VAC14&#8211;HA</italic>
###xml 1135 1145 1109 1119 <italic>vac14-2&#8211;HA</italic>
###xml 1155 1156 1129 1130 <bold>F</bold>
###xml 1175 1182 1149 1156 <italic>vac14-2</italic>
###xml 734 739 <span type="species:ncbi:4932">Yeast</span>
Vac7p and Atg18p function through Vac14p. (A) vac14-2 has smaller than normal vacuoles, consistent with elevated basal levels of PI(3,5)P2. vac14Delta cells expressing pRS416-VAC14 or pRS416-vac14-2 labelled with FM4-64. (B) vac14-2 has higher basal levels of PI(3,5)P2, but does not elevate or turnover PI(3,5)P2 during osmotic stress. PI(3,5)P2 levels in vac14Delta cells expressing pRS416-VAC14 or pRS416-vac14-2 measured as described in Figure 4. Error bars: s.d. (n=3). (C) vac14-2 protein is present at wild-type levels. Cell lysates analysed by western blot analysis from vac14Delta cells expressing pRS413-VAC14-HA (WT) or pRS413-vac14-2-HA(14-2). Pgk1p: loading control. (D) Vac14-2 is defective in binding Vac7p and Atg18p. Yeast two-hybrid test of VAC14 or vac14-2, fused with Gal4-AD, interaction with FAB1, FIG4, VAC7, ATG18, fused with Gal4-BD. Upper panel, SC-LEU-TRP (control); lower panel: SC-LEU-TRP-ADE-HIS +3AT (test). Plates incubated at 24degreesC, 7 days. (E) Fab1p coprecipitates vac14-2. Detergent-solubilized extracts from a vac14Delta or vac14Delta/FAB1-TAP strain expressing pRS413-VAC14-HA (WT), or pRS413-vac14-2-HA (14-2). (F) Schematic of the vac14-2 allele; blue arrows indicate the mutation sites.
###end p 138
###begin p 139
###xml 237 242 237 242 <italic>VAC14</italic>
###xml 256 261 256 261 <italic>VAC14</italic>
###xml 286 290 286 290 <italic>FAB1</italic>
###xml 322 326 322 326 <italic>VAC7</italic>
###xml 369 374 369 374 <italic>ATG18</italic>
###xml 378 382 378 382 <italic>FIG4</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid analysis of the minimal region of Vac14p required for interaction with Fab1p, Fig4p, Vac7p, and Atg18p. Lines above the schematic indicate the minimal region of Vac14p required for binding with each protein. Full-length VAC14 or truncated VAC14 was fused with Gal4-AD. FAB1 encoding amino acids 538-1085, VAC7 encoding amino acids 394-918: full-length ATG18 or FIG4 was fused with the BD. Lines below the schematic indicate the regions of Vac14p tested.
###end p 139
###begin p 140
###xml 29 30 29 30 <bold>A</bold>
###xml 50 51 50 51 <bold>B</bold>
###xml 233 234 233 234 <sub>2</sub>
###xml 637 648 637 648 <italic>vac14-ingls</italic>
Model of the Vac14 complex. (A) Schematic Vac14. (B) Vac14p binds to both Fab1p and Fig4p and may undergo a conformational change that brings Fab1p into contact with Fig4p. Fig4p functions as both an activator of Fab1p and a PI(3,5)P2 5-phosphatase. Fig4p and Fab1p bind to distinct regions on Vac14p. The Fab1p-binding site significantly overlaps with Vac7p- and Atg18p-binding sites. Blue arrowheads indicate the vac14-2 mutations sites, the arrow to the left indicates the location of H56Y and R61K, the arrow to the right marks Q101R. These arrows show the region of Vac14p that contacts Vac7p and Atg18p. Red asterisk indicates the vac14-ingls mutation, which disrupts interaction with Fab1p, Vac7p, and Atg18p.
###end p 140

